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COMMENTS
MAY AN EMPLOYER REQUIRE
EMPLOYEES TO WEAR “GENES”
IN THE WORKPLACE?
AN EXPLORATION OF TITLE II OF
THE GENETIC INFORMATION
NONDISCRIMINATION ACT OF 2008
ERIN MURPHY HILLSTROM*
I. INTRODUCTION
On May 21, 2008, President George W. Bush signed into law the Genetic Information Nondiscrimination Act of 2008 (“GINA”).1 This law became effective almost seven years after President Bush stated, before the
nation, that genetic discrimination is “unfair to workers” and it “violates
our country’s belief in equal treatment.”2 GINA is federal legislation
that was enacted to address genetic discrimination3 by preventing
* I want to thank all of the members of The Journal of Computer and Information
Law for assisting me with the editing process, especially Erica Bertini. I would also like to
thank my family for supporting and encouraging me, especially my sister Ellen Murphy.
Finally, I would like to dedicate this comment to my husband Eric.
1. Coalition for Genetic Fairness, President Bush Signs Landmark Genetic Nondiscrimination Information Act Into Law, http://www.geneticfairness.org/action_alert11.html
(last visited Sept. 30, 2008) [hereinafter President Signs GINA].
2. President George W. Bush, Presidential Radio Address to the Nation (June 23,
2001), available at http://www.whitehouse.gov/news/releases/2001/06/20010623.html. In
his radio address to the nation, President Bush stated:
[g]enetic discrimination is unfair to workers and their families. It is unjustified—
among other reasons, because it involves little more than medical speculation. A
genetic predisposition toward cancer or heart disease does not mean the condition
will develop. To deny employment or insurance to a healthy person based only on
a predisposition violates our country’s belief in equal treatment and individual
merit. Id.
3. President Signs GINA, supra note 1; but see The Equal Employment Opportunity
Commission (“EEOC”), Facts About the ADA: Americans with Disabilities Act, http://www.
eeoc.gov/facts/fs-ada.html (last visited Nov. 26, 2008) [hereinafter Facts About the ADA]

501

\\server05\productn\S\SFT\26-4\SFT404.txt

502

unknown

Seq: 2

JOURNAL OF COMPUTER & INFORMATION LAW

20-APR-10

7:54

[Vol. XXVI

health insurance providers and employers from discriminating against
individuals based on genetic information.4 Title I of GINA, which addresses health insurance providers, went into effect May 2008 and Title
II, which addresses employers, went into effect November 2009.5
GINA protects the health of individuals by ensuring that those who
take genetic tests will not be discriminated against by employers and
health care providers.6 GINA makes it illegal for health care providers
and employers to discriminate against individuals based on their genetic
information.7 More specifically, under Title I of GINA, group health plan
and health insurance issuers “shall not request, require, or purchase genetic information with respect to any individual prior to such individual’s enrollment under the plan or coverage in connection with such
enrollment.”8 Title II of GINA prohibits an employer from requesting
that either prospective or current employees undergo genetic testing and
prohibits an employer from using genetic test results in making promotional or hiring decisions.9
This comment will focus on the employer provisions of GINA, as set
forth under Title II of the act.10 Congress’ purpose in enacting GINA
(discussing the proper use of medical examinations offering an inference that genetic testing is a type of medical examination, and therefore covered under the Americans with Disabilities Act of 1990 (“ADA”)); National Human Genome Research Inst., Existing Federal
Anti-Discrimination Laws and How They Apply to Genetics, http://www.genome.gov/
12513979 (last visited Nov. 26, 2008) [hereinafter Existing Federal Laws] (noting that an
argument can be made that genetic discrimination is prevented under Title VII of the Civil
Rights Act of 1964 (“Title VII”) where an employer discriminates against an employee
based on a genetic trait that is substantially linked to a race or ethnic group).
4. H.R. 493, 110th Cong. § 2 (2008); see also President Signs GINA, supra note 1.
5. Id.
6. Coalition for Genetic Fairness, Current Status of GINA, http://www.geneticfairness.org/ginaresource_history.html#2 (last visited Oct. 5, 2008) [hereinafter Current Status
of GINA].
7. Id.
8. H.R. 493, 110th Cong. § 101(d)(2) (2008); see also Genetic Alliance, How Does GINA
Impact Me?, http://www.geneticalliance.org/ginaresource.impact (last visited Oct. 29, 2008)
[hereinafter How Does Gina Impact Me?] (noting that The Genetic Information Nondiscrimination Act of 2008 (“GINA”) prohibits both group and individual health insurance
companies from “requesting or requiring” genetic testing of an individual or her family
members or relying on genetic information to determine eligibility for coverage or setting
premiums).
9. H.R. 493, 110th Cong. § 202 (2008) (citing those employer practices that are prohibited under Title II of GINA); see also How Does GINA Impact Me?, supra note 8. GINA
prevents labor organizations and employment agencies from discriminating against individuals based on their genetic makeup. Id. Additionally, employers cannot make decisions
regarding an individual’s acceptance into an employee training program based on the individual’s genetic makeup. Id.
10. This comment focuses solely on the employer provisions of GINA. While GINA
prevents genetic discrimination in general, there are two distinct areas of application: employer provisions and health insurance provisions. The health insurance provisions are
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was to eliminate an individual’s fear of genetic discrimination and to encourage individuals to undergo genetic testing.11 While there is a legitimate purpose for Congress to encourage individuals to undergo genetic
testing, Congress acted prematurely by passing a statute directly focusing on genetic discrimination before a court had an opportunity to interpret whether current federal law would have adequately prevented
genetic discrimination.
As an illustration of how genetic discrimination may occur in the
workplace, consider the following hypothetical. Jean, a thirty-year-old
woman revealed to a fellow employee that she had a family history of
Huntington’s disease.12 Soon after her employer discovered this information, Jean received a series of negative job reviews, despite a history
outside the scope of this comment. See Coalition for Genetic Fairness, Current Status of
GINA, http://www.geneticfairness.org/act.html (last visited Oct. 5, 2008) (noting that there
were two purposes for enacting GINA; first, to prevent health insurance providers from
discriminating against an individual based on genetic information and second, to prevent
employers from discriminating against employees in regards to their terms of employment
based on genetic information).
11. See The Library of Congress, Summary of the Genetic Nondiscrimination Act of
2008, http://thomas.loc.gov/cgi-bin/bdquery/z?d110:HR00493:@@@L&summ2=M& (last visited Nov. 5, 2008); see also Exec. Order No. 13,145, 65 Fed. Reg. 6877 (2000) (noting that
there are limitations on the federal government prohibiting disability-related inquiries and
medical examinations of government employees under the ADA); see also H.R. 493, 110th
Cong. § 2 (2008) (citing findings and purposes for enacting GINA).
12. See Council for Responsible Genetics, Genetic Discrimination: A Position Paper,
available at http://www.councilforresponsiblegenetics.org/ViewPage.aspx?pageId=85 [hereinafter Council for Responsible Genetics]; see also National Nat’l Institute Inst. of Neurological Disorders and Stroke (“NINDS”), Huntington Disease Information Page, available at
http://www.ninds.nih.gov/disorders/huntington/huntington.htm [hereinafter Huntington’s
Disease].
Huntington’s disease (“HD”) is a result of, “genetically programmed degeneration of brain
cells, called neurons, in certain areas of the brain.” Id. This degeneration can cause, “uncontrolled movements, loss of intellectual faculties, and emotional disturbance.” Id. HD is
a disease passed down to a child from his parents through a mutated gene. Id. Every child
that has an HD parent has a fifty percent (50%) likelihood of inheriting this gene. Id. If a
child with an HD parent does not inherent the mutated gene linked to HD, she will not
develop HD and will not pass the defective gene on to one of her children or any subsequent
generations. Id. Additionally, “whether one child inherits the gene has no bearing on
whether others will or will not inherit the gene.” Id. Every single person with the mutated
HD gene will develop HD sooner or later. Id. Early symptoms of HD include, “mood swings, depression, irritability or trouble driving, learning new things, remembering a fact, or
making a decision.” Id. HD is diagnosed by a conducting a genetic test, laboratory and
neurological tests, and family medical history. Id. There is no way to reverse the effects of
HD once the disease has manifested. Id. See also J.F. Gusella et al., A Polymorphic DNA
Marker Genetically Linked to Huntington’s Disease, 306 NATURE 234, 234-38 (1983) (noting
that the gene mutation that causes Huntington’s disease is located in the tip of chromosome four); see also Brian R. Gin, Genetic Discrimination: Huntington’s Disease and the
Americans with Disabilities Act, 97 COLUM L. REV. 1406, 1414 (1997) (noting that the discovery of the genetic mutation that causes Huntington’s disease was hailed as one of the
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of good performance evaluations and promotions.13 Jean was later fired,
and subsequently learned that she had been fired because her employer
expressed concerns about Jean developing Huntington’s disease.14 The
employer did not want to continue to train Jean as an employee if she
would leave the workforce prematurely because of her predisposition for
developing Huntington’s disease.15
This hypothetical illustrates one way an employer could discriminate against an employee based on her genetic information. There is a
real threat that an employer may use an individual’s genetic test results
against an employee.16 Therefore, Congress enacted GINA with the intention of providing individuals with a minimum level of protection from
their employers’ misuse of their genetic information.17 Because the provisions of GINA are confusing, however, GINA will not have the intended
effect of sufficiently preventing genetic discrimination. GINA’s broad
definitions and provisions frustrate compliance, and will cause a surge in
litigation.18
It is important for employers to note that the employer provisions of
GINA took effect on November 21, 2009. Taking the mandatory steps to
ensure that employers are in compliance will reduce an employer’s exposure to potential litigation by employees for violations of GINA. Additionally, ensuring that an employer is in compliance with the law could
afford the employer a good faith argument if an employee files a claim
against the employer for violating GINA.
As previously stated, GINA was enacted prematurely. GINA is
problematic because Congress enacted GINA before a court was afforded
an opportunity to decide whether employees asserting claims of genetic
very first successes in the process of mapping the human genome, and led to an expansion
in genetic research).
13. See Tara L Rachinsky, Genetic Testing Toward a Comprehensive Policy to Prevent
Genetic Discrimination in the Workplace, 2 U. PA. J. LAB. & EMP. L. 575, 576 (2000).
14. Id.
15. Id.; see also Nat’l Partnership for Women & Families, Faces of Genetic Discrimination: How Genetic Discrimination Affects Real People (July 2004), available at http://www.
geneticalliance.org/ksc_assets/documents/facesofgeneticdiscrimination.pdf (noting that
many employees potentially lost out on the benefits of early detection and preventative
health care measures because of their fear of genetic discrimination) [hereinafter Faces of
Genetic Discrimination].
16. See Rachinsky, supra note 13 at 582 (noting, for example, an employer could research genetic diseases, make a determination on which diseases cost the most in terms of
health coverage and time away from the job, screen applicants for a predisposition for the
disease, and refuse to hire those individuals with a higher predisposition); see also Faces of
Genetic Discrimination, supra note 15.
17. See The Library of Congress, supra note 11.
18. See Kevin P. McGowan, Employer Advocates Remain Wary of New Bias Law’s Potential Effects, [May] Daily Lab. Rep., (BNA) at C-1 (May 22, 2008), available at http://
emlawcenter.bna.com/pic2/em.nsf/id/BNAP-7KMKU9?OpenDocument.
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discrimination could have been afforded redress under other federal
laws. Other federal laws, such as Title VII of the Civil Rights Act of 1964
(“Title VII”) and the American’s With Disabilities Act of 1990 (“ADA”),
could have been relied upon by the courts to redress cases in which employees alleged genetic discrimination.19 Because these statutes already
afforded adequate protection, GINA will cause compliance issues for employers and because GINA affords an employee a new right of action,
GINA will also increase litigation.20 Therefore, it is important to note
that this comment should not be construed as adopting an opinion
counter to the realization of the important policy goals of protecting individuals from discrimination based on their genetic information, and affording redress to those who have been discriminated against. However,
GINA is both premature and insufficient to adequately ensure that these
goals are met.
In terms of realizing human longevity, genetic testing is one of the
greatest accomplishments of the new century.21 This comment will first
provide a brief discussion of genetics and genetic testing. Section II of
this comment will provide a basic introduction on genetics, genetic testing, and genetic discrimination. Additionally, Section II will provide a
brief overview of current federal laws that address genetic discrimination in the workplace. Finally, Section II will examine the major employment provisions of GINA.
Section III of this comment will examine whether there was a need
for GINA, and will argue that GINA will not have the full effect intended
by Congress. The major sources of litigation under GINA will then be
reviewed based on the articulated issues. With these potential sources of
litigation in mind, Section III will suggest to employers necessary steps
that should be taken to ensure that the employer is in compliance with
the provisions of GINA. Finally, Section III will examine some of the
public-policy concerns legislators should keep in mind when they revisit
and amend GINA in the future. Section IV will provide a brief
conclusion.

19. See 42 U.S.C. § 2000(e)(2) (1990); Facts About the ADA, supra note 3; see generally
42 U.S.C. § 12101 (2008).
20. See McGowan, supra note 18.
21. See Press Release, Snowe Calls for Passage of Genetics Nondiscrimination Bill:
Gina is the “first civil rights act of the 21st century” (April 22, 2008), available at http://
snowe.senate.gov/public/index.cfm?FuseAction=PressRoom.PressReleases&ContentRecord
_id=77c1bf5a-802a-23ad-4efb-6f1fbc897ab0&IsPrint=true [hereinafter Snowe]. It is important to note that this comment should not be construed as adopting an opinion counter to
the realization of the important policy goals of protecting individuals from discrimination
based on their genetic information and affording those who have been discriminated
against with redress.
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II. BACKGROUND
To understand GINA, it is important to have some background knowledge on genetics. Therefore, the first part of this section provides basic
information on genetics, genetic testing, and genetic discrimination. The
second part of this section explores the specific provisions of GINA and
Congress’ intent in enacting the legislation. The third part of this section lists current federal laws that have been enacted to address workplace discrimination. The final part of this section outlines the employer
provisions of GINA, as set forth under Title II.
A. PRIMER

ON

GENETICS

Genes are the building blocks of human beings, and function as the
human body’s blueprint.22 This blueprint is designed by the unique set
of genes each individual inherits from their mother and father.23 These
genes determine an individual’s physical characteristics, such as eye and
hair color. However, genes also determine characteristics which cannot
be seen with the human eye, such as whether an individual is susceptible
to developing a certain genetic disease later in life, including heart disease or cancer.24 Every human being has a unique genetic code; no two
people have the same genetic information.25
1. Genetic Information
To understand what a genetic test is, it is helpful to understand the
basics of genetic information. “Genetic information is contained in the
DNA of every living organism.”26 According to Microsoft Encarta:
Genes are composed of segments of deoxyribonucleic acid [“DNA”], a
molecule that forms the long, threadlike structures called chromosomes. The information encoded within the DNA structure of a gene
directs the manufacture of proteins, molecular workhorses that carry
22. Christine Formas Norris, The Genetic Information Nondiscrimination Act of 2008:
History, Successes and Future Considerations, 7 U. MD. L.J. RACE, RELIGION, GENDER &
CLASS 192, 193 (2007).
23. See Kids Health, What is a Gene?, http://kidshealth.org/kid/talk/qa/what_is_gene.
html (last visited Nov. 1, 2008).
24. Anthro Limited, Inheriting Eye Color, http://www.athro.com/evo/gen/genefr2.html
(last visited Oct. 30, 2008); see also Faces of Genetic Discrimination, supra note 15 (stating
that, “a genetic predisposition to heart disease or cancer does not mean that the condition
will develop”).
25. KRISTINE BARLOW-STEWART, THE AUSTRALASIAN GENETICS RESOURCE BOOK 1-4 (6th
ed. 2007), available at http://www.whoisyourcreator.com/assets/PDF%27s/ChangesToTheGenetic_Code.pdf.
26. See Rivka Jungreis, Fearing Fear Itself: The Proposed Genetic Information Nondiscrimination Act of 2005 and Public Fears About Genetic Information, 15 J.L. & POL’Y 211,
213 (2007) (stating each strand of DNA is composed of two- paired strands of nucleotides
which are twisted together into a double- helical structure).
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out all life-supporting activities within a cell. DNA is the genetic material of all cellular organisms and most viruses. A molecule of DNA consists of two chains, strands composed of a large number of chemical
compounds, called nucleotides, linked together to form a chain. These
chains are arranged like a ladder that has been twisted into the shape
of a winding staircase, called a double helix. Human genes reside on 23
pairs of chromosomes found in the nucleus of every cell in the body except gamete cells called genomes.27

Human DNA is sorted into twenty-three matched sets of chromosomes that direct the cell to perform a specific function.28 It is estimated
that humans have between thirty-two and thirty-five thousand genes.29
Ninety-nine point nine percent (99.9%) of the human genome is exactly
the same in all human beings.30 The remaining one-tenth of a percent
(.1%) is what makes each individual unique.31 The genes that differ between each human being help to account for the various ways an individual will respond to an infection, disease, toxins, chemicals, and drug
therapies.32
2. Genetic Testing
An individual’s unique genes are important to geneticists who rely on
large genetic databases for their research.33 In order for geneticists to
collect genetic information, an individual must undergo a genetic test.34
Genetic testing involves any technique that analyzes human DNA or
proteins.35 Healthcare providers have historically used genetic tests as a
27. Microsoft Encarta Online Encyclopedia, Deoxyribonucleic Acid, http://encarta.msn.
com/encyclopedia_761561874/Deoxyribonucleic_Acid.html (last visited Sept. 9, 2009).
28. Jungreis, supra note 26 at 213.
29. Electronic Privacy Information Center, Genetic Privacy, http://epic.org/privacy/ge
netic (last visited Oct. 20, 2008) [hereinafter Genetic Privacy].
30. Id.
31. Id.; see also BARLOW-STEWART, supra note 25 (explaining that a genetic test is used
in order to determine what small variants make an individual unique).
32. Genetic Privacy, supra note 29 (explaining only identical twins, triplets, etc. have
identical DNA).
33. See Council for Responsible Genetics, supra note 12.
34. See Genetics Home Reference, What is a genetic testing?, http://ghr.nlm.nih.gov/
handbook/testing/genetictesting (last visited Sept. 9, 2009).
35. Genetics Home Reference, What is DNA?, http://ghr.nlm.nih.gov/handbook/basics/
dna (last visited Oct. 29, 2008); Genetics Home Reference, What are Proteins?, http://
ghr.nlm.nih.gov/handbook/howgeneswork/protein (last visited Oct. 29, 2008). Proteins are
large complex molecules that perform critical roles in the body. Id. Proteins perform the
majority of the work in a cell and “are required for the structure, function, and regulation of
the body’s tissues and organs.” Id. Proteins are composed of “hundreds or thousands of
smaller units called amino acids, which are attached to one another in long chains.” Id.
There are, “twenty different types of amino acids that can be combined to make a protein.
Id. The sequence of amino acids determines each protein’s unique three-dimensional structure and its specific function.” Id.; See also National Institute of Health, Promoting Safe
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tool to detect gene variations associated with a specific disease or health
condition, and for non-diagnostic matters such as paternity testing and
forensic science.36 Uses of genetic tests include: early detection of genetic diseases in fetuses; determining whether parents pose a risk of
passing a mutated gene to their child; discovery of genetic diseases
before symptoms of the disease develop; or confirmation of a doctor’s diagnosis of a genetic disease before an individual has developed
symptoms.37
A genetic test encapsulates any alterations in an individual’s genes
by looking at changes in the level of key proteins coded for by specific
genes.38 If an abnormality is detected, the gene is flagged, and could be
evidence that an individual has an inherited disorder.39 Currently,
there are tests available to diagnose thousands of different diseases.40
Three main types of genetic tests currently relied upon by geneticists are
and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic
Testing, http://www.genome.gov/10002393 (last visited Sept. 9, 2009) [hereinafter Safe and
Effective Testing]. The analysis of human DNA, RNA, chromosomes, proteins, and certain
metabolites in order to detect inheritable disease-related genotypes, mutations, phenotypes, or karyotypes for clinical purposes. Id. Such purposes include predicting risk of
disease, identifying carriers, and establishing prenatal and clinical diagnosis or prognosis.
Id. Prenatal, newborn, and carrier screening, as well as testing in high risk families, are
included. Id.
36. National Human Genome Research Institute, Genetic Testing, http://www.genome.
gov/10002335 (last visited Oct. 29, 2008) [hereinafter NHGRI Genetic Testing].
37. Medline Plus, Genetic Testing, http://www.nlm.nih.gov/medlineplus/genetictesting.
html (last visited Sept. 24, 2008).
38. National Human Genome Research Institute, A Brief Primer on Genetic Testing,
http://www.genome.gov/10506784 (last visited Sept. 9, 2009). There are three different
types of genetic tests gene tests, chromosomal test, and biochemical tests. Id. A gene test
looks at a DNA sample from an individual’s blood, bodily fluid, or tissues, and assesses the
sample for any large changes such as a missing section, a gene with too many copies, an
overactive gene, or an altered chemical base. Id. A chromosomal test centers on the structure of the nucleus of a cell containing DNA. Id. This test looks for any chromosomes that
have been switched or that are located in the wrong position. Id. Finally, a biochemical
test looks at the level of key proteins to determine whether or not a gene is functioning
properly. Id.
39. National Human Genome Research Institute, Frequently Asked Questions About
Genetic Testing, http://www.genome.gov/19516567 (last visited Sept. 9, 2009).
40. Faces of Genetic Discrimination, supra note 15 (stating scientists have identified
genetic markers for cancer, diabetes, Alzheimer’s disease, Huntington’s disease, cystic fibrosis, and thousands of others); See also The Potential for Discrimination in Health Insurance Based on Predictive Genetic Test: Hearing Before the Subcomm. on Commerce, Trade
and Consumer Protection of the H. Comm. on Energy and Commerce, 107th Cong. (2001),
available at http://www.geneticalliance.org/PDF/GAtestimony.pdf (publishing the testimony of Mary E. Davidson, Executive Director, Genetic Alliance); National Institute of
Health Consensus Development Program, Genetic Testing For Cystic Fibrosis, http://www.
nih.gov/news/pr/apr97/nihod-09.htm (last visited Nov. 8, 2008); Associated Press, Discovery
Could ID Diabetes-Risk Kids, http://www.khccgroup.com/item.php?IID=16 (last visited
Sept. 8, 2009).
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diagnostic, predictive, and carrier tests.41
A person, who shows signs or symptoms of a genetic disease, can
undergo a diagnostic test in order to confirm a diagnosis of a particular
disease.42 Diagnostic tests can be performed before birth or at any time
during an individual’s life.43 Likewise, a predictive test determines if an
individual has a higher probability of developing a disease before symptoms of a disease are present.44 A predictive test reveals diseases such
as breast cancer, colorectal cancer, and polyps.45 If parents are concerned about passing on inherited disorders, they could undergo a carrier
test.46 A carrier test can determine whether an individual is a carrier of
certain defective genes that could be passed on to their children.47 Diseases such as Huntington’s disease, Tay-Sachs, and Cystic Fibrosis can
be detected by carrier tests.48
41. NHGRI Genetic Testing, supra note 36.
42. Id.
43. Genetics Home Reference, What are the Types of Genetic Tests?, http://ghr.nlm.nih.
gov/handbook/testing/uses (last visited Nov. 21, 2008).
44. NHGRI Genetic Testing, supra note 36.
45. Myriad, Understanding Inherited Breast and Ovarian Cancer, http://www.
myriadtests.com/brac.htm (last visited Sept. 29, 2008). Each year approximately 200,000
women are diagnosed with breast cancer and 25,000 women with ovarian cancer. Id. Of
these cases, approximately ten percent (10%) are due to hereditary genetic predispositions.
Id. Women of the Ashkenazi or Eastern European Jewish ancestry are at higher risk of
carrying this genetic mutation. Id. Of the 30,000 genes that we inherit from our parents,
the BRCA-1 and BRCA-2 genes prevent a woman from developing breast cancer. Id. In
some cases, a mutation or alteration occurs to this gene causing an individual to be more
susceptible to developing breast cancer. Id.
46. NHGRI Genetic Testing, supra note 36.
47. Id.
48. Huntington’s Disease, supra note 12; National Institute of Neurological Disorders
and Stroke (“NINDS”), Tay-Sachs Disease Information Page, http://www.ninds.nih.gov/disorders/taysachs/taysachs.htm (last visited Nov. 16, 2008) [hereinafter Tay-Sachs]. TaySachs disease is a “fatal genetic lipid storage disorder in which harmful quantities of a
fatty substance called ganglioside GM2 build up in tissues and nerve cells in the brain.” Id.
This process is caused by “insufficient activity of an enzyme called beta-hexosaminidase A
that catalyzes the biodegradation of acidic fatty materials known as gangliosides.” Id.
Gangliosides are “made and biodegraded rapidly in early life as the brain develops.” Id.
An infant that has Tay-Sachs disease will appear normal in the beginning of his developmental stage. Id. However, “as nerve cells become distended with fatty material, a relentless deterioration of mental and physical abilities occurs including deafness, blindness, and
an inability to swallow.” Id. Tay-Sachs also causes muscles to atrophy, causing the infant
to become paralyzed. Id. Tay-Sachs can also develop later on in life in patients in their
early twenties and thirties. Id. Patients developing Tay-Sachs later in life often experience gait and neurological deterioration. Additionally, individuals with Tay-Sachs usually
have “cherry-red” spots in their eyes. Id. Tay-Sachs can be identified by a blood test that
measures an individual’s level of beta-hexosaminidase A activity. Id. In order for an individual to have Tay-Sachs disease, both of her parents must carry the mutated gene. Id. If
both parents are carriers of the mutated gene, there is a twenty-five percent (25%) chance
that their child will have Tay-Sachs. Id. There is currently no treatment for Tay-Sachs.
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The results of genetic tests are also utilized by geneticists to develop
the individualized medicine industry.49 The development of the individual medicine industry is made possible by the newest form of genetic
testing: pharmacogenomic testing.50 This type of test determines how
drugs move through the body and are broken down into particles that the
body can absorb.51 In the future, genetic testing could be used to specifically tailor drug treatments to each individual person, ensuring each individual receives the right amount of medicine to treat a disease.52
With advancements in genetic testing over the past few years, the
price of undergoing a genetic test has fallen dramatically.53 There are
now direct-to-consumer kits that will scrutinize over six billion points of
your genetic makeup for around $1,000.54 If more than one family member participates, the genetic test could show inherited traits such as athletic endurance or bitter taste blindness.55
3. Genetic Discrimination
Since the completion of the Human Genome Project in 2000, researchers have been concerned about genetic discrimination.56 An individual
who chooses to undergo genetic testing makes a decision not only to disId. Even with current medical advancements, children diagnosed with Tay-Sachs usually
die by age four as a result of recurring infection. Id.; see also The American College of
Obstetricians and Gynocology, Cystic Fibrosis Carrier Testing: The Decision is Yours, http:/
/www.acog.org/from_home/wellness/cf001.htm (last visited Nov. 8, 2008) [hereinafter Cystic
Fibrosis]. The purpose of carrier testing for cystic fibrosis is to allow a couple to determine
whether they have an increased chance of giving birth to a child who will suffer from this
disease. Id. Cystic fibrosis is a double-impaired genetic disease. Id. This means that in
order for a child to inherit the genetic disorder, both parents have to be a carrier of a
mutated or altered gene. Id. Carrier testing for cystic fibrosis is conducted on a sample of
either saliva or blood from the couple. Id. While there is nothing that can be done in the
prenatal stage to treat or cure this disease in the fetus, and later the child, the purpose of
the test is to prepare couples to care for a child who will require special health care needs.
Id.
49. Council for Responsible Genetics, supra note 12.
50. National Institute of Health: Department of Health and Human Services NIH
Publication # 07- 6283 (Aug. 2007), available at http://www.genome.gov/Pages/Health/
PatientsPublicInfo/GeneticTestingWhatItMeansForYourHealth.pdf [hereinafter NIH
Publication].
51. Id.
52. Id.
53. Matt Ransford, Genetic Testing: Cheaper, Easier (Apr. 24, 2004), available at http://
www.popsci.com/scitech/article/2008-04/genetic-testing-cheaper-easier.
54. Thomas Goetz, 23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of
Genomics, WIRED, Nov. 17, 2007, at 256, available at http://www.wired.com/medtech/genetics/magazine/15-12/ff_genomics.
55. Id.
56. See Genetic Discrimination in Health Insurance, What is the Issue?, http://www.
genome.gov/10002328 (last visited Oct. 28, 2008).
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close private medical information about himself, but also about every
other person who shares his genetic makeup.57 This fear has led some
individuals to forgo genetic testing in order to prevent being discriminated against by their health insurance provider and employer.58 A
2007 survey, conducted by the Genetics and Public Policy Center, found
that ninety-two percent (92%) of the respondents were concerned that
genetic tests that revealed a risk of developing future disease could be
used against them by their employers and health care providers.59 The
survey reported that most respondents were concerned that their genetic
information would be used to deny them employment.60
If individuals are concerned about genetic discrimination, they can
meet with a genetic counselor who will discuss with them the benefits
and drawbacks of undergoing genetic testing.61 Genetic counseling, a
service that usually accompanies a genetic test, involves a genetic counselor who informs an individual of the risks associated with undergoing a
genetic test.62 A genetic counselor’s role is to provide an individual with
the realistic outcomes of receiving a positive test result for a specific disease to provide the individual with realistic expectations for treatment
options and to inform an individual about current legal safeguards regarding their genetic information.63
B. CURRENT FEDERAL LAWS ENACTED TO PREVENT
EMPLOYMENT DISCRIMINATION
Genetic discrimination can be in the form of employment discrimination.64 Two federal acts that cover employment discrimination are Title
VII and the ADA.65 Title VII was enacted by Congress in order to pre57. Id.
58. Genetics and Public Policy Center, US Public Opinion on Uses of Genetic Information and Genetic Discrimination, http://www.dnapolicy.org/resources/GINAPublic_Opinion
_Genetic_Information_Discrimination.pdf. See also Faces of Genetic Discrimination, supra
note 15. Kim was a social worker with a human services agency. Id. She was fired by her
employer after she disclosed during a staff workshop on caring for people with chronic illness that her mother had died of Huntington’s disease. Id. Based on her genetics, Kim had
a 50% of developing Huntington’s herself. Id. One week later Kim was fired despite outstanding performance reviews. Id.
59. Genetics and Public Policy Center, supra note 58 (reporting while eighty-six percent (86%) of respondents reported that they would trust health care providers not to misuse the information, over ninety-three percent (93%) replied that this information should
not be used by employers in hiring and promotion related decisions).
60. Id.
61. Amy Adams, What is Genetic Counseling?, Genetic Health, Dec. 4, 2003, available
at http://www.genetichealth.com/Resources_What_Is_Genetic_Counseling.shtml.
62. Id.
63. Id.
64. See H.R. 493 110th Cong. § 2 (2008).
65. See 42 U.S.C. § 2000(e)(2) (1990); Facts About the ADA, supra note 3.
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vent an employer from discriminating against employees or potential
employees on the basis of race, color, religion, sex, or national origin.66
The ADA was enacted in 1990 to prevent employers from discriminating
against individuals with disabilities.67 The ADA imposes legal consequences upon employers who wrongly correlate an individual’s disability
with an inability to perform a particular job or job function.68 Under
both Title VII and the ADA, an employer may not discriminate against
any individual on the basis of one of the above mentioned protected classes with regard to the terms of employment.69
1. Title VII of the Civil Rights Act of 1964
Title VII prohibits discrimination based on an individual’s race, color,
religion, sex, or national origin.70 As set forth in Title VII, if an individ66. U.S. EEOC, Federal Laws Preventing Job Discrimination: Questions and Answers,
http://www.eeoc.gov/facts/qanda.html (last visited Nov. 15, 2008) [hereinafter Federal
Laws].
67. Education for Disability and Gender (“EDGE”), Why Did the Government Need to
Enact the American’s With Disabilities Act (ADA)?, http://www.disabilityhistory.org/dwa/
edge/curriculum/gov_contenta2.htm (last visited Nov. 15, 2008); Education for Disability
and Gender (“EDGE”), What Does the ADA Do?, http://www.disabilityhistory.org/dwa/edge/
curriculum/gov_contenta3.htm (last visited Nov. 15, 2008).
68. Id.
69. Federal Laws, supra note 66. Under federal law it is illegal for an employer to
discriminate against an individual regarding any aspect of employment including: hiring
and firing; compensation, assignment or classification of employees; transfer, promotion,
layoff, or recall; job advertisements; recruitment; testing; use of company facilities; training
and apprenticeship programs; fringe benefits; pay, retirement plans, and disability leave;
or other terms or conditions of employment. Id. Discrimination under both the ADA and
Title VII includes: harassment on the basis of race, sex, color, religion, national origin,
disability or age; retaliation against an individual for filing a charge of discrimination, participating in an investigation, or opposing a discriminatory practice; employment decisions
based on stereotypes or assumptions about the abilities, traits or performance of individuals of certain sex, race, age, religion, or ethnic group or individuals with disabilities; or
denying employment opportunities to an individual because of marriage to or association
with an individual of a particular race, religion, national origin, or an individual with a
disability. Id. Also, Title VII prohibits discrimination because of participation in schools or
places of worship associated with a particular race, ethnic, or religious group. Id.
70. GEORGE RUTHERGLEN, EMPLOYMENT DISCRIMINATION LAW: VISIONS OF EQUALITY IN
THEORY AND DOCTRINE 6-8, (Foundation Press 2d ed. 2007). The provisions of Title VII set
forth the “most important of the statutory prohibitions against employment discrimination
and the one that most clearly expanded upon the protection offered by the Constitution.”
Id. Title VII expanded the protection of employees from discrimination by private entities
(i.e. employers), which are beyond the scope and force of the Fifth and Fourteenth Amendments. Id. Title VII incorporated the fair employment practices set forth in state law into
federal law. Id. The provisions incorporated from state law into Title VII were “exceedingly broad, covering all aspects of employment: hiring, discharge, compensation, fringe
benefits, conditions of work, and anything else connected with employment.” Id. Title VII
also expanded the grounds for impermissible discrimination to add additional characteristics besides racial discrimination, including discrimination based upon national origin, re-
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ual believes he or she has been the victim of discrimination, the individual first files a claim with the Equal Employment Opportunity
Commission (“EEOC”).71 The EEOC then conducts an investigation to
determine whether the individual’s claim has merit.72 Upon determining that an individual’s claim has merit, the EEOC has three courses of
action: attempt to settle the matter with the employer on behalf of the
employee; filing suit on behalf of the employee; or issue the individual a
right-to-sue letter.73
To bring a Title VII claim for genetic discrimination, an individual
must have a predisposition to a disease that is specific to his race or ethnic category.74 Protection under Title VII is only available if an employer engaged in discriminatory practices based on a genetic trait
substantially related to a specific race or ethnic group.75 An individual’s
claim for redress under Title VII may rely on either of two theories: disparate treatment or disparate impact.76 In order to rely upon a disparate treatment theory, a plaintiff must prove by direct and
circumstantial evidence that his employer intentionally discriminated
against him because of his membership in a Title VII protected class.77
Alternatively, under a disparate impact claim, a plaintiff must prove
that a facially neutral policy (in this case genetic testing) is discriminatory in effect.78 If a plaintiff is successful in establishing a prima facie
case, then the burden shifts to the employer to show that the genetic test
ligion, and sex. Id. Race and national origin are protected under the Fifth and Fourteenth
Amendments; religion is protected under the religious clause of the First Amendment; sex
was expressly protected by Supreme Court interpretation. Id.; 42 U.S.C. § 2000(e)(2)
(1990). Title VII prohibits employment discrimination based on race, color, religion, sex, or
national origin. Id. Section 2000(e)(2) provides that:
it shall be unlawful employment practice for an employer to fail or refuse to hire or
to discharge any individual or otherwise to discriminate against any individual
with respect to his compensation, terms, conditions, or privileges or employment,
because of such individual’s race, color, religion, sex, or national origin; or to limit,
segregate, or classify his employees or applicants for employment in any way
which would deprive or tend to deprive any individual of employment opportunities or otherwise adversely affect his status as an employee, because of such individual’s race, color, religion, sex, or national origin. Id.
71. H.R. 483, 110th Cong. § 207(a)(1) (2008); see also 42 U.S.C. § 2000(e)(2) (1990).
72. 42 U.S.C. § 2000(e)-5(b) (2007).
73. McGowan, supra note 18.
74. Existing Federal Laws, supra note 3.
75. Id.
76. Melinda B. Kaufmann, Genetic Discrimination in the Workplace: An Overview of
Existing Protections, 30 LOY. U. CHI. L.J. 393, 419 (1999).
77. Jared A. Feldman & Richard J. Katz, Genetic Testing & Discrimination In Employment: Recommending A Uniform Statutory Approach, HOFSTRA LAB. & EMP. L. J. 389, 401
(2002).
78. Id. at 405.
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is job-related or a matter of business necessity.79 To bring a Title VII
claim for genetic discrimination, an individual has to be predetermined
to have a disease linked to a specific racial or ethnic category.80 Protection under Title VII is only available if an employer engaged in discriminatory practices based on a genetic trait substantially related to a
specific race or ethnic group.81
2. The Americans with Disabilities Act
The ADA is another federal act to ban employment discrimination.82
The ADA prevents an employer from discriminating against an individual based on a real or perceived disability.83 The regarded as prong (perceived disability) directly relates to discrimination of an employee by an
employer.84 The regarded as prong of the ADA was enacted to prevent
discrimination where an employer erroneously believed an employee or
prospective employee was disabled and treated the employee differently
because of that erroneous belief.85
Additionally, under Title I of the ADA, an employer may not ask a
job applicant or employee about the existence, nature, or severity of a
real or perceived disability.86 In the pre-employment stage, an employer
cannot require an individual to undergo a medical examination.87 Once
an offer has been extended, and before the individual is hired as an employee, the ADA sets forth, “a covered entity may require a medical examination after an offer of employment has been made to a job applicant,
and prior to the commencement of the employment duties of such applicant, and may condition an offer of employment on the results of such
79. Kaufmann, supra note 76. “Business necessity” is defined as relating to an employment practice and an individual employee’s ability to perform requisite job functions. Id.
“Job-relatedness” is applicable when an employer proves that the criteria it relies upon to
select employees for a specific job fit within the demands of the job. Id. A court will usually
rely upon a balancing test to determine whether genetic testing is permissible and in line
with the employer’s ultimate objective. Id.
80. Existing Federal Laws, supra note 3.
81. Id.
82. Facts About the ADA, supra note 3.
83. Id.
84. Id.
85. The National Workrights Institute (“NWI”), Genetic Discrimination and the Americans with Disabilities Act: An Unlikely Fit, http://www.workrights.org/issue_genetic/
gd_ada.html (last visited Nov. 1, 2008) (emphasis added).
86. Facts About the ADA, supra note 3.
87. 42 U.S.C. § 12112(d)(2)(A), (3), (4)(B) (1994) (noting that an employer may notify
an applicant that a job offer will be contingent upon that individual’s consent to undergoing
a routine medical examination, and passing that exam, as long as it is required of all
applicants).
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examination.”88 Once an employee is hired, an employer cannot require
that the employee undergo medical testing to determine whether or not
the employee suffers from a disability.89 In fact, employers may only
require an employee undergo job-related examinations that are consistent with business necessity.90
In addition to preventing an employer from requesting medical information or testing, Title I of the ADA requires any medical records obtained by an employer regarding an employee, be kept confidential.91
Furthermore, information can be classified as confidential even if there
is no medical diagnosis or treatment listed on the document.92 A document may be confidential under the ADA even if it is not created by a
health care professional.93 Under Title I of the ADA, however, there are
a few limited situations where an employer may disclose an employee’s
88. 42 U.S.C. § 12112(d)(3) (1994). In order for an employer to utilize these tests in his
employment process there is a three-prong test that must be satisfied to ensure that his use
does not violate the provisions of the ADA. Id. First, the employer must test all employees
applying for employment, regardless of whether or not there is a disability. Id. Second, the
information collected from these exams must be maintained on separate forms and in a
separate medical file and treated as confidential information. Id. Third, the employer
must ensure that any results from the medical examination are used only in accordance
with the provisions of the sub-chapter. Id. See also U.S. EEOC, Questions and Answers
About Cancer in the Workplace and the Americans with Disabilities Act (ADA): Notice Concerning the Americans With Disabilities Act Amendments Act of 2008, http://www.eeoc.gov/
facts/cancer.html (last visited Oct. 29, 2008) [hereinafter Cancer in the Workplace]. Once
an employer has extended a position to an individual applicant, it may ask questions about
an applicant’s current health status and could require a medical examination so long as all
other applicants are subjected to that same test. Id. This request for medical information
regarding an applicant may only occur once the employer has obtained, reviewed, and evaluated all other non-medical application information, and made the job offer “real” pending
a medical examination. Id.
89. Larry Gostin, Genetic Discrimination: The Use of Genetically Based Diagnostic and
Prognostic Tests by Employers and Insurers, 17 AM. J.L. & MED. 109, 132 (1991).
90. Id. (stating medical tests for non-job-related purposes are impermissible because
they could not yield any legitimate employer purpose).
91. Facts About the ADA, supra note 3.
92. Id.
93. Id. See also Arizona Center for Disability law, The Americans with Disabilities Act
(ADA) and Confidentiality of Medical Information, Oct. 10, 2001, at 8, available at http://
www.acdl.com/pdfs/E7.pdf. Any medical information obtained through an employer requested medical examination, or test result obtained regarding an employee, is clearly covered by the confidentiality provisions of the ADA. Id. Additionally, if an employer obtains
medical information during the course of employment regarding any employee from any
other source, that information would also be subject to the confidentiality provisions under
the ADA. Id. See also 42 U.S.C. § 12112(d)(3)(A)-(C) (1994). For an employer to give a
“conditional examination” to prospective employees, three elements must be satisfied: first,
the examination must be given to all entering employees regardless of disability. Id. Second, the information obtained must be collected and maintained in a confidential manner.
Id. Third, the statute requires that the results of any medical examination may be used
only in accordance with the non-discrimination requirements of the statute. Id.
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confidential medical information.94
C. THE GENETIC INFORMATION NONDISCRIMINATION ACT

OF

2008

GINA was enacted into law in May 2008, after thirteen years of debate
before Congress.95 Previous drafts of GINA were before the House of
Representatives since 1995, and the Senate since 1996.96 Congress decided to enact GINA to provide clear and consistent protections over genetic information, replace inadequate state laws, and provide a uniform
federal standard preventing genetic discrimination.97
GINA assures, as a matter of law, that neither health insurers nor
employers can use employees’ genetic information to discriminate.98
Under Title I of GINA, health insurance providers cannot require an individual to provide genetic information or family genetic information
when making a determination about eligibility, coverage, underwriting,
or premiums.99 Additionally, health insurance providers may not use
genetic information collected from an individual, intentionally or incidentally, to determine whether or not to provide that individual with
coverage.100 Under Title I, healthcare providers may not require an individual or an individual’s family members to undergo genetic testing as
a condition of extending coverage.101 GINA ensures that an individual
who voluntarily chooses to undergo genetic testing will not face any
discrimination.102
GINA, however, does not prevent discrimination in life, disability, or
94. 42 U.S.C. §12112(d)(3)(A)-(C) (1994).
95. President Signs GINA, supra note 1.
96. Current Status of GINA, supra note 6. Both the 1995 and 1996 bills addressed
genetic discrimination in the health insurance industry, however, neither bill was passed
by the 104th Congress. Id. A second attempt was made in 2002 before the 107th Congress,
which addressed genetic discrimination by both health insurance providers and employers
but also failed. Id. Legislation was introduced again before the 108th Congress in the
House of Representative as H.R. 1910 and gained 242 co-sponsors. Id. Identical legislation
was introduced in the Senate as S. 1053 and gained 23 co-sponsors. Id. The legislation
passed in the Senate by a vote of 95-0; however the legislation failed in the House. Id.
Legislation again was introduced before the 109th Congress. Id. The genetic discrimination bill was introduced in the House as H.R. 1227 and gained 244 co-sponsors. Id. The bill
was introduced in the Senate as S. 306. Id. The bill passed once again in the Senate by a
vote of 98-0, however failed in the House once again. Id.
97. Genetics and Public Policy Center, supra note 58; Current Status of GINA, supra
note 6 (noting GINA was introduced on January 16, 2007, by bipartisan team Representatives Slaughter, Biggert, Eshoo, and Walden).
98. Kathy L. Hudson, Prohibiting Genetic Discrimination, 365 NEW ENG. J. MED. 2021,
2021-22 (2007) available at http://dceg.cancer.gov/files/genomicscourse/hudson072607.pdf.
99. How Does GINA Impact Me?, supra note 8.
100. H.R. 493, 110th Cong. § 101 (2008).
101. How Does GINA Impact Me?, supra note 8.
102. Id.
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long-term-care insurance markets.103 Nor does GINA prevent disclosure
of an individual or family member’s already diagnosed genetic disease.104 Also, GINA does not preempt more extensive protections afforded under state law.105
Under Title II, an employer may not use genetic information for hiring, promotional decisions, conditions of employment, privileges of employment, compensation, or in making termination decisions.106
Employers may neither require individuals to undergo genetic testing,
nor fail to refer an individual for employment based on their genetic information.107 An employer may only have access to an employee’s genetic information if the information is provided inadvertently, through
publicly available sources, or with the written authorization of the
individual.108
Furthermore, an individual’s genetic information may not be disclosed except with the individual’s written express consent, court order,
or ordered under existing laws to federal, state, or local authorities.109
Title II of GINA applies to those employers covered under Title VII.110
This means employers with fewer than fifteen employees are exempt
from GINA’s provisions.111
Title II of GINA was enacted to prevent “workplace discrimination
based upon an individual’s genetic information.”112 GINA is the first
federal legislation specifically targeted at preventing genetic discrimination.113 According to the provisions of GINA, “genetic information includes information regarding: (i) an individual’s genetic tests; (ii) genetic
test of the individual’s family members; as well as (iii) the manifestation
of a disease or disorder in an individual’s family members.”114 Genetic
information also covers an employee’s request for genetic services.115
Genetic services incorporate genetic tests, genetic counseling, and ge103. Id.
104. Id.
105. Id.
106. Genetics & Public Policy Center, Information on the Genetic Information Nondiscrimination Act, http://www.dnapolicy.org/resources/WhatGINAdoesanddoesnotdochart.
pdf [hereinafter Information on GINA].
107. Id.
108. Id.
109. Id.
110. Id.
111. Id.
112. Eric N. Miller, The Genetic Information Nondiscrimination Act of 2008, ALI-ABA
2013, 2015 (2008).
113. Id.
114. Id.
115. Id.
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netic education.116
Employer is defined the same under Title II of GINA and Title
VII.117 Thus, the term employer includes some government agencies.118
GINA broadly sets forth a general rule whereby:
[I]t is unlawful for an employer, because of an employee’s genetic information, to: (i) fail or refuse to hire, or to discharge the employee; (ii)
otherwise discriminate against the employee with respect to the compensation, terms, conditions, or privileges of the employment of the employee; or (iii) limit, segregate, or classify the employee in any way that
would deprive (or tend to deprive) the employee of employment opportunities or adversely affect the status of the employee.119

Under Title II, an employer may not request, require, or purchase
genetic information regarding an employee or an employee’s family
member.120 There are, however, a number of limited exceptions when an
employer may obtain genetic information about an employee or employee’s family member.121 For instance, an employer may obtain genetic information if related to a request for time off under the Family
Medical Leave Act (“FMLA”).122
Title II provides limited situations where an employer may disclose
genetic information regarding an employee.123 An employer may only
disclose information:
(i) to the employee at his or her written request, (ii) in connection with
certain research activities, (iii) in response to a court order, (iv) to government officials who are investigating compliance with Title II of
GINA, if the genetic information is relevant to the investigation, (v) to
the extent necessary in connection with the employee’s certification requirements under the FMLA, or (vi) to a Federal, State or local public
health agency that concerns a contagious disease that presents an imminent hazard of death or life-threatening illness.124

Congress enacted GINA to prevent genetic discrimination in the
workplace by setting forth a number of safeguards for an employee’s genetic information under Title II.125 According to GINA, employers may
not request genetic information from an employee or employee’s family
116. Id.
117. Id. at 2017(stating that employers subject to Title VII of the Civil Rights Act of
1964 includes any employer that employs fifteen or more employees); see also H.R. 493,
110th Cong. §201(B) (2008).
118. Miller, supra note 112.
119. H.R. 493 110th Cong. § 202(a)(1)-(2) (2008).
120. Miller, supra note 112.
121. Id. at 2015.
122. Miller, supra note 112.
123. H.R. 493, 110th Cong. § 202(b) (2008); see also Miller, supra note 112.
124. Miller, supra note 112; see also H.R. 493, 110th Cong. § 202(b) (2008).
125. H.R. 493, 110th Cong. § 201 (b) (2008).

\\server05\productn\S\SFT\26-4\SFT404.txt

2009]

unknown

Seq: 19

GENES IN THE WORKPLACE

20-APR-10

7:54

519

members.126 Disclosure of an employee’s genetic information is permissible under a few limited circumstances.127
Additionally, an employer has a duty to ensure a minimum level of
confidentiality regarding the genetic information of an employee.128 Title II sets forth a minimum level of confidentiality required for employers
who have, or will, obtain genetic information about its employees. Title
II requires an employer to keep its employee’s genetic information separate from other medical information.129 This is similar to the current
requirement that employers keep an employee’s medical information
separate from the employee’s personnel information on file with the employer.130 Maintaining genetic information separately from other medical information reduces the risk of the genetic information being
improperly accessed or disclosed by employers.131
III. ANALYSIS
GINA is a federal law that specifically addresses the issue of genetic
discrimination, and was enacted after Congress concluded that Title VII
and the ADA were insufficient to remedy employment discrimination
based on a genetic predisposition to developing a disease. A genetic test
merely reports the likelihood that an individual could one day suffer
from a potentially life-threatening disease, and does not guarantee that
an individual will develop the disease.132 Therefore, Congress argued
that specific legislation was warranted to address this form of employment discrimination. However, GINA is duplicative and will not have
the effect Congress intended.
A. GINA IS DUPLICATIVE

AND

PREMATURE

While GINA has been hailed as the first piece of civil rights legislation
in the twenty-first century, there is much debate as to whether GINA is
necessary.133 Some critics of GINA argue that current federal law could
have prevented genetic discrimination, making GINA duplicative and
126. Id.
127. H.R. 493 110th Cong. § 206(b) (2008). For example, an employer may be required
to disclose an employee’s genetic information in response to a court order. Id.
128. H.R. 493, 110th Cong. § 206(a) (2008).
129. Miller, supra note 112.
130. Id.
131. Id.
132. See NATIONAL HUMAN GENOME RESEARCH INSTITUTE, FINAL REPORT
OF THE TASK FORCE ON GENETIC TESTING Ch. 1 (1997) available at http://www.
genome.gov/10002405.
133. Snowe, supra note 21.
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unnecessary.134 Based on the current broad protections set forth under
the ADA and Title VII, it is arguable that employees were adequately
protected from genetic discrimination under current federal laws.
Additionally, GINA is premature because Congress enacted GINA
before a court decision was handed down addressing whether current
federal law was sufficient to prevent genetic discrimination. First, there
have only been two cases of genetic discrimination filed in federal courts,
evidencing that this is not a common issue for employees. Second, a
court has never been afforded an opportunity to apply current federal
discrimination laws to an employee’s complaint of genetic
discrimination.
1. Genetic Discrimination Is Protected by the ADA
The ADA is the federal law most often cited by critics as sufficient for
preventing genetic discrimination.135 There are two main provisions set
forth under the ADA that could have been used for genetic discrimination.136 First, as previously discussed, the regarded as prong of the ADA
adequately protected employees from discrimination based on their genetic information.137 Second, the ADA’s limitations on employee examinations, and the confidentiality requirement regarding an employee’s
medical records could have prevented genetic discrimination in the
workplace.138
134. See Ron Zapata, Genetic Anti-Bias Bill Rouses Litigation Fears, EMPLOYMENT LAW
360, May 21, 2008 at 5. L Lawrence Z. Lorber commenting, “If there is no problem to deal
with, why are we passing a law?” Id. In reference to the fact that over thirty states have
laws preventing genetic discrimination and that no claims have been filed on the violation
of those laws. Id. Additionally, a survey of Chamber members reported that “many businesses were unaware of genetic testing and would never pay for it.” Id. The case that was
filed against Burlington Northern for its non-consensual testing of its employers for a genetic predisposition for carpal tunnel syndrome is an exceptional case and should not be
deemed as evidencing that there is a larger problem of genetic discrimination generally in
the employment setting. Id. Burlington Northern as an outlier occurrence is further evidenced by the lack of litigation in the area, which could imply that there is a lack of employers requiring that employees undergo genetic testing. Id.
135. Facts About the ADA, supra note 3. Title I of the ADA prohibits, “private employer,
state and local government, employment agencies, and labor unions from discriminating
against qualified individuals with disabilities in job application procedures, hiring, firing,
advancement, compensation, job training, and other terms, conditions, and privileges of
employment.” Id. The act, “covers employers with 15 or more employees, including state
and local governments, and also applies to employment agencies and to labor organizations.” Id.
136. Cancer in the Workplace, supra note 88 (stating that the EEOC has made a determination that an asymptomatic genetic condition is considered a disability under the
ADA).
137. Id. (emphasis added).
138. Id.; see also Committee on Education and Labor, ADA Amendments Act of 2008,
http://edlabor.house.gov/ada-amendments-act-of-2008/index.shtml (last visited Nov. 2,
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Proponents of GINA argue that neither of the provisions under the
ADA are sufficient combat genetic discrimination. First, there is no clear
legislative history evidencing that Congress intended to include asymptomatic genetic conditions under the regarded as prong of the ADA.139
An individual who is asymptomatic is a carrier of a mutated gene that
could cause a genetic disease to manifest later in life.140 This means an
individual who has a likelihood of manifesting a disease later in life
would not be considered currently disabled under the ADA.141 Additionally, because an individual may never develop a genetic disease, additional safeguards are needed for medical testing of employees.142
However, it takes an extremely broad interpretation of the ADA to
cover genetic discrimination.143 Under the regarded as prong, any indi2008). The ADA Amendments Act of 2008 was signed into law on September 25, 2008. Id.
The Act overturns the, “erroneous Supreme Court decisions that have eroded the protections for people with disabilities under the ADA, restoring original Congressional intent.”
Id. The Act affirmatively rejects the Court’s prior “strict interpretation of the definition of
disability, and makes it absolutely clear that the ADA is intended to provide broad coverage to protect anyone who faces discrimination on the basis of disability.” Id. The amendments also seek to reach a “balance between employer and employee interests.” Id. The
amendments also “cover[s] people who experience discrimination based on a perception of
impairment regardless of whether the individual experiences a disability.” Id. Additionally, the Act also sets forth, “reasonable accommodations are only required for individuals
who can demonstrate they have an impairment that substantially limits a major life activity, or a record of such impairment; accommodations need not be provided to an individual
who is only ‘regarded as’ having an impairment.” Id. See also Tiffany Hildreth, 2008 ADA
Amendments Act, Sept. 23, 2008, http://www.strasburger.com/calendar/news/labor/ADAAmendments-Act-of-2008.htm.
139. E-medicine Health, Practical Guide to Health: Definition Asymptomatic, http://
www.emedicinehealth.com/script/main/art.asp?articlekey=9790 (last visited Nov. 1, 2008)
(defining asymptomatic as “without symptoms”; for example an asymptomatic infection is
an infection without symptoms); Paul Steven Miller, Genetic Discrimination in the Workplace, 26 J.L. MED. & ETH. 189, 190 (1998).
140. NWI, supra note 85. Coverage under the ADA requires that a person have a current disability. Id. According to the NWI, it is “clear that the ADA would potentially cover
genetic discrimination in employment after a disease with genetic origins has left its host
disabled.” Id. However, because an individual who has been diagnosed through a genetic
test only potentially could develop the disease later in life, their symptoms or condition is
asymptomatic. Id. Since the conditions and symptoms have not yet manifested in an individual they could not currently be classified as disabled, and therefore are, “unlikely to be
impaired in a major life activity,” a condition required for relief under the ADA. Id.
141. Id. (emphasis added).
142. 42 U.S.C. § 12112(a) (1994); see also Paul Steven Miller, Is There a Pink Slip in My
Genes? Genetic Discrimination in the Workplace, 3 J. HEALTHCARE L. & POL’Y 225, 238
(2000).
143. Zapata, supra note 134, at 4. Genetic discrimination actions, before GINA’s passage and implementation, could have been brought under the “regarded as” prong of the
ADA because genetic discrimination could be categorized as a perceived physical or mental
impairment. Id. Lawrence Z. Lorber states, “[i]f you lost your job because you are presumed to have a physical condition, than you have an ADA action. . .therefore why pass a
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vidual who is assumed to have a major life impairment is considered to
be disabled.144 The regarded as standard is subjective, reflecting the
mindset of each individual employer regarding its determination of
whether an employee is disabled.145 The definition of disability also incorporates an individual with a disability that is not immediately known
by an employer.146 Likewise, the regarded as prong of the ADA prevents
an employer from discriminating against an employee based on preconceived notions of any of the individual’s limitations.147 The ADA can
protect genetic information, because it extensively limits an employer’s
ability to collect, use, and disclose medical information.148 Therefore,
the ADA protects genetic information, because it prohibits an employer
law when you’re already covered?” Id. Additionally, Reed Russel, legal counsel for the
EEOC, states, “GINA makes it easier to frame a complaint because of GINA’s broader basis
of coverage.” See also Cancer in the Workplace, supra note 88.
144. See Cancer in the Workplace, supra note 88 (emphasis added).
145. NWI, supra note 85 (emphasis added).
146. Cancer in the Workplace, supra note 88 (emphasis added). An applicant is not required under the ADA to disclose to his employer information regarding a disability, such
as whether the individual has cancer, unless he will need a reasonable accommodation
during the application process. Id. An individual may also request a reasonable accommodation for a disability after becoming an employee, even if she did not ask for the reasonable accommodation during the application stage. Id.
147. Id. “Cancer is a disability under the ADA if it, or a side effect, substantially
limit(s) one or more of a person’s major life activities.” Id. For example:
following a lumpectomy and radiation for aggressive breast cancer, a computer
sales representative experienced extreme nausea and constant fatigue for six
months. She continued to work during her treatment, although she frequently
had to come in later in the morning, work later in the evening to make up the time,
and take breaks when she experienced nausea and vomiting. She was too exhausted when she came home to cook, shop, or do household chores, and had to
rely almost exclusively on her husband and children to do these tasks. This individual’s cancer is a disability because it substantially limits her ability to care for
herself. Id.
Cancer may also be considered a disability because it has “substantially limited an individual to perform a major life activity sometime in the past.” Id. For example:
a company president was hospitalized for 30 days immediately following his diagnosis of blood cancer. Because his treatment, which included chemotherapy and a
bone marrow transplant, weakened his immune system, he was unable to care for
himself for six months and had to avoid interactions with almost everyone except
his doctors, nurses, and immediate family members. Id.
This individual would be regarded as having a, “record of disability.” Id. Finally, cancer is
regarded as a disability even if it does not affect a person’s major life activities, but the
employer treats the individual as if it does. Id. For example:
an individual with a facial scar from surgery to treat skin cancer applies to be an
airline customer service representative. The interviewer refuses to consider him
for the position because she fears that his scar will make customers uncomfortable. In basing her decision not to hire on the presumed negative reactions of the
customers, the interviewer is regarding the applicant as substantially limited in
working in any job that involves interacting with the public. The employer is
treating the applicant as if he has a disability. Id.
148. Id.

\\server05\productn\S\SFT\26-4\SFT404.txt

2009]

unknown

Seq: 23

GENES IN THE WORKPLACE

20-APR-10

7:54

523

from discriminating against individuals based on their medical
information.149
Additionally, genetic testing could have been covered as a medical
examination under the ADA.150 A genetic test could be considered a medical examination, thereby subjecting the use of genetic information by
employers to the same use requirements as other medical
examinations.151
Finally, the current judicial trend further evidences a broad interpretation of the regarded as prong of the ADA. This current trend has
allowed individuals who do not fit within the traditional definition of disabled under the ADA to enforce the ADA’s restrictions on medical testing
under the statute.152 Therefore, even if a genetic defect was not considered a disability under the ADA, the statute would still prevent an employer from requiring that an employee undergo a genetic test.153 Both
the historically broad application of the regarded as prong as well as the
current judicial trend evidences that GINA is duplicative, because the
ADA adequately prevents genetic discrimination.
In addition to the historical and current interpretation of the courts,
the EEOC has interpreted the ADA to prevent genetic discrimination.154
149. Philip L. Gordon & Jennifer L. Mora, Genetic Antidiscrimination Law Creates New
Compliance Challenges for Employers, ASAP May 2008, available at http://www.jdsupra.
com/post/documentViewer.aspx?fid=2711c1fd-da19-408c-b8ee-04e4b1330648.
150. The Genetic Discrimination Nondiscrimination Act: Hearing Before the Subcomm.
on Health of the H. Comm. on Energy and Commerce, 110th Cong. (2007) (statement of
Burton J. Fishman, on behalf of the Genetic Information Nondiscrimination in Employment Coalition) (emphasis added) [hereinafter Energy and Commerce Hearing]. The Genetic Information Nondiscrimination in Employment Coalition (“GINE”) is a business
association comprised of trade associations, professional organization, and individual companies. Id. GINE’s main focus is addressing the, “prevention of genetic non-discrimination
in employment.” Id. GINE’s major issue with GINA is the fact that the bill focuses as
written on the “flow” of genetic information instead of focusing on the potential, “discriminatory misuses” of genetic tests and information. Id. Because GINA focuses on the “flow,”
and not on discrimination, according to GINE, “the bill will inevitably be plagued by serious, negative, albeit unintended consequences.” Id.
151. Id.
152. Id.; see also Griffin v. Steel Tech, Inc., 160 F.3d 591, 594 (10th Cir. 1998); Fredenburg v. Contra Costa County Dept. of Health Services, 172 F.3d 1176, 1182 (9th Cir. 1999).
153. Energy and Commerce Hearing, supra note 151.
154. Press Release, The United States Equal Employment Opportunity Commission,
EEOC Settles ADA Suit Against BNSF For Genetic Bias (Apr. 18, 2001) available at http://
www.eeoc.gov/eeoc/newsroom/release/archive/4-18-01.html (last visited Sept. 23, 2008)
[hereinafter EEOC Settles ADA Suit]. The press release provides:
EEOC is a federal agency responsible for enforcing Title I of the ADA, which prohibits discrimination against qualified individuals with disabilities, including
prohibiting an employer from seeking disability related information not related to
an employee’s ability to perform his or her job. In addition, EEOC enforces Title
VII of the Civil Rights Act of 1964, which prohibits discrimination on the bases of
race, color, religion, sex, or national origin; the Age Discrimination in Employment
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The EEOC has interpreted the ADA’s regarded as prong to prevent an
employer from discriminating against an individual based on her genetic
information.155 If an employer has genetic information regarding an individual and uses this information to discriminate against the employee,
the employee would have an actionable claim under the ADA.156 However, because a court has never been afforded an opportunity to uphold
the EEOC’s interpretation of the ADA as applying to genetic information, it lacks the full force and effect of a law.157
In EEOC v. Burlington Northern Santa Fe Railway Company, the
EEOC interpreted the ADA as covering genetic testing.158 Burlington
Northern conducted genetic testing on its employees without their consent or knowledge.159 Burlington Northern conducted genetic testing in
Act, which protects workers 40 and older; and the Equal Pay Act which prohibits
sex-based differences in compensation. Id.
In the case between the EEOC and Burlington Northern Santa Fe Railroad (“BNSF”), the
EEOC filed a preliminary injunction against BNSF to prevent irreparable harm to the employees of the company who could potentially lose their jobs based on their genetic makeup.
Id. By settling the suit, the EEOC ensured that employees would not be subject to retaliation or future privacy invasions in violation of the American’s with Disabilities Act. Id.
According to the petition filed by the EEOC on behalf of BNSF employees, genetic tests
were being performed on employees without their knowledge or consent. Id. See also Cancer in the Workplace, supra note 88; Genetic Non-Discrimination: Implications for Employers and Employees: Hearing before the Subcomm. on Employer-Employee Relations of the H.
Comm. on Education and the Workforce, 107th Cong. (2001) (statement of Mr. Gary Avary,
Member of the Brotherhood of Maintenance and Way Employees and Employee of Burlington Northern Santa Fe Railroad Company), available at http://www.edworkforce.house.gov/
hearings/107th/eer/ genetic72401/ avary.htm.
What happened to me should not happen to anyone especially in the United
States. It is a direct infringement on our fundamental right to be who we are. No
one can help how they are put together, only God knows that—your employer,
insurance companies or anyone else has no business of that knowledge. That information. . . should not be used against you and your family for hiring and firing
practices, or acceptance and/or denial into insurance programs. Id.
155. EEOC Settles ADA Suit, supra note 155 (emphasis added).
156. Id.
157. Agreed Order at EEOC v. Burlington N. Santa Fe R.R. Co., No. 01-4013 MWB
(N.D.L.A. Apr. 23, 2001) [hereinafter Agreed Order]; see also Press Release, The United
States Equal Employment Opportunity Commission, EEOC Petitions Court to Ban Genetic
Testing of Railroad Workers in First EEOC Case Challenging Genetic Testing Under
Americans With Disabilities Act (Feb. 9, 2001) available at http://www.eeoc.gov/press/2-901-c.html.
158. EEOC v. Burlington N. Santa Fe R.R. Co., Civ. No. 01-4013 MWB (N.D. Iowa Apr.
18, 2001) (granting preliminary settlement agreement); see also Agreed Order, supra note
158.
159. EEOC Settles ADA Suit, supra note 155. In Burlington Northern Santa Fe v.
EEOC, the EEOC filed a charge on behalf of BNSF’s employees who had been tested, without their consent or knowledge, for genetic predisposition for carpal tunnel syndrome. Id.
The group of employees had filed a worker’s compensation claim with the company for
developing carpal tunnel syndrome as a result of their employment duties. Id. BNSF had
also threatened one of its workers with termination if he failed to comply with the medical
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order to determine whether its employees had developed carpal tunnel
syndrome as a result of work conditions, or whether the employees had a
genetic predisposition to develop the disease.160 The EEOC relied on the
legal argument that the Burlington Northern had violated the ADA by
requiring employees to undergo testing that was neither job-related nor
consistent with business necessity.161 The court was not afforded an opportunity to determine whether or not genetic testing could have been
prevented under the ADA because the case settled out of court.162
test. Id. The EEOC determined that the non-consensual genetic testing of employees violated the ADA because the test was not job-related. Id. The EEOC deemed that a predisposition to developing a disease in the future had absolutely no correlation to an
individual’s current ability to perform his job, and therefore conditioning the terms of an
individual’s employment based on the likelihood that he could later develop a disease was
actionable as discrimination founded on a disability. Id. See also, Robert B. Lanman, An
Analysis of the Adequacy of Current Law in Protecting Against Genetic Discrimination in
Health Insurance and Employment, at 17 (May 2005), available at http://www4.od.nih.gov/
oba/SACHGS/reports/legal_analysis_May2005.pdf. The Health and Human Services Secretary’s Advisory Committee on Genetic, Health, and Society commissioned a study in 2005
on whether current laws could adequately protect an individual from employers and health
insurance providers from discriminating against him. Id. The study was assisted by the
contributions of the Department of Labor, Department of Justice, EEOC, Centers for Medicare & Medicaid Services and Office for Civil Rights. Id. This study was used as a basis for
drafting the new GINA which was enacted into law in May, 2008. Id.; see also Interview
with Jean Kamp, Associate Regional Attorney, U.S. Equal Employment Opportunity Commission, in Chicago, Ill. (Oct. 7, 2008) (on file with author) [hereinafter Kamp Interview].
160. EEOC Settles ADA Suit, supra note 155; see also Kamp Interview, supra note 160.
161. Kamp Interview, supra note 160; see also Medline Plus, Carpal Tunnel Syndrome,
http://www.nlm.nih.gov/medlineplus/carpaltunnelsyndrome.html (last visited Nov. 15,
2008) [hereinafter Carpal Tunnel Syndrome]. The carpal tunnel is a narrow passageway of
ligaments and bones at the base of an individual’s hand. Id. The passageway contains
both nerves and tendons. Id. Sometimes, thickening from irritated tendons or other swelling narrows the tunnel and causes the nerve to be compressed. Id. Carpal tunnel syndrome is usually caused by one of two problems; an individual may inherit narrow carpal
tunnels, and therefore have a genetic predisposition to develop the disease, or an individual
may develop the disease from assembly line work, wrist injury or other disease such as
rheumatoid arthritis. Id. Women are three times more likely than men to develop carpal
tunnel syndrome. Id. Treatments of the disease include resting, splints, pain and antiinflammatory medicines and surgery. Id.
162. Brief of Plaintiff at 1, U.S. EEOC v. Burlington N. Santa Fe R.R. Co., No.06-6074
(E.D. Wis. 2002). The EEOC filed suit on behalf of BNSF employees who were required to
undergo genetic testing in response to a company policy mandating genetic testing of all
individuals who claimed to have developed carpal tunnel syndrome. Id. The EEOC stated
that while BNSF employees were told that they would undergo, “laboratory testing,” at no
time did BNSF disclose that blood samples would be taken and sent to a genetic testing
facility and analyzed. Id. Instead of informing its employees about the genetic testing, it
was the wife of one employee who was a nurse that inquired as to why her husband was
required to undergo blood work as, “part of a purported ‘medical examination’ of whether
his carpal tunnel syndrome was work-related.” Id. It was in response to the nurse’s inquiry on behalf of her husband that she learned that the tests being performed by BNSF
were genetic tests. Id. See also Norman-Bloodsaw v. Lawrence Berkeley Lab., 135 F.3d
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2. Title VII Additionally Prevents Genetic Discrimination
Title VII also prevents employers from discriminating against individuals based on their genetic makeup. In order to bring a Title VII claim
for genetic discrimination, an individual must be predisposed to a genetically linked disease specific to a racial or ethnic category.163 Protection
under Title VII is only available if an employer engaged in discriminatory practices based on a genetic trait substantially related to a specific
race or ethnic group.164 Only a few genetic diseases, however, have been
scientifically linked to race, or ethnicity. For example, discrimination
based on Tay-Sachs, which has a high incidence among Eastern Europeans and Ashkenazi Jews, would be actionable because the disease is
linked to a protected category of religion or national origin.165 Therefore, only a few genetic diseases would be actionable on the basis of a
Title VII claim.166
There are only a few types of genetic diseases that may only be developed by males or females. For example, only men can develop prostate cancer.167 Therefore, in regards to the protected class of sex, if an
employer were to discriminate on the basis of prostate cancer, this discrimination would be actionable under Title VII because this type of disease is linked to a particular gender.168
Proponents of GINA point out that this legislation was needed based
on a shortfall in coverage under Title VII.169 This argument lacks merit,
because Title VII should not be interpreted as being limited in its cover1260, 1273 (9th Cir. 1998) (applying the ADA to plaintiffs’ genetic claim holding that the
ADA was not violated because the plaintiffs merely challenged the scope of the medical
testing examinations which is not protected under the ADA).
163. Susan M. Wolf & Jeffery P. Kahn, Genetic Testing and the Future of Disability
Insurance: Ethics, Law & Policy, 35 J. L. MED. & ETHICS 6, 8 (2007). The case was settled
out of court for $2.2 million. Id.
164. Existing Federal Laws, supra note 3.
165. Id.
166. Id.
167. National Cancer Institute, What You Need to Know About Prostate Cancer, http://
www.cancer.gov/cancertopics/wyntk/prostate/page2 (last visited Nov. 23 2009).
168. Tay-Sachs, supra note 48.
169. Phoenix5, Where Is Your Prostate and What Does It Do?, http://www.phoenix5.org/
Infolink/Physiology.html (last visited Nov. 16, 2008). Only men have prostates, therefore
only men may develop prostate cancer. Id. A man’s prostate is a solid organ located immediately below his bladder. Id. The prostate controls both bladder and sexual functions.
Id.; see also Tirgan Oncology Associates, Prostate Cancer, http://www.tirgan.com/genetics/
genprostate.htm (last visited Nov. 16, 2008). The most prevalent cancer among American
men is prostate cancer. Id. Annually, approximately 250,000 American men are diagnosed
with prostate cancer. Id. The risk of developing prostate cancer increases as a man gets
older. Id. Most men are diagnosed with prostate cancer over the age of sixty. Id. AfricanAmerican men carry an increased risk of approximately ten percent of developing the disease during their life. Id.
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age, rather it should be viewed as providing additional coverage to individuals. If an employee was discriminated against not only because of
results of a genetic test, but also for being a member of a protected category, he could bring a Title VII claim as well as an ADA claim.170 Therefore, Title VII should not be regarded as limiting, rather, it should be
considered as providing additional protections against genetic
discrimination.
A Title VII violation for genetic discrimination was brought before
the Ninth Circuit in Norman Bloodsaw v. Lawrence Berkeley Laboratory.171 In that case, the plaintiffs were former employees of a research
institute operated by state and federal agencies in California.172 The
plaintiffs alleged that during a mandatory employment entrance exam,
their employer tested their blood and urine for private medical conditions without their knowledge or consent. Specifically, the plaintiffs alleged that the blood samples of African-Americans were screened for
sickle-cell anemia and syphilis, and the urine samples of female applications were tested for pregnancy.173 The district court dismissed the
plaintiffs’ claims and entered judgment for the defendant.174
On appeal, the Ninth Circuit held that the employer violated Title
VII by making these testing distinctions based on the alleged classification of race and sex, and that the employees had demonstrated an ad170. See Existing Federal Laws, supra note 3 (noting to rely on Title VII for a genetic
discrimination claim there must be a strong relationship between race or national origin
which has only been established for a few diseases).
171. Norman-Bloodsaw, 135 F.3d at 1260.
172. Id. at 1273. Plaintiffs, African-American former employees, brought both a Title
VII claim and ADA claim against defendants alleging non-consensual genetic testing.
173. Id. at 1264.
174. Id. at 1265; see also Medline Plus, Sickle Anemia, http://www.nlm.nih.gov/medlineplus/ency/article/000527.htm. Sickle cell anemia is also referred to as Hemoglobin SS
disease. Id. Sickle cell anemia is a disease in which an individual produces abnormally
shaped red blood cells. Id. The cells are misshapen like a crescent or a sickle as opposed to
normal round blood cells. Id. Since the cells are misshapen, they do not last as long as
normal blood cells which leads to anemia. Id. Another problem with sickle shaped cells is
that they get caught in blood vessels, restricting the flow of blood. Id. A genetic abnormality causes sickle cell anemia. Id. Individuals who have the disease receive defective genes
from both of their parents who are carriers of the defective gene. Id. Approximately one in
every twelve African-Americans has sickle cell anemia. Id. A blood test can determine
whether or not an individual has the disease. Id. Therefore, most babies of African-American decent are tested for sickle cell anemia. Id. See also The Sickle Cell Anemia Center,
Frequently Asked Questions (FAQ): Sickle Trait and Malaria Protection, http://www.scinfo.
org/faqtrait.htm (last visited Nov. 15, 2008). The highest prevalence of sickle cell anemia
occurs in individuals of African and Mediterranean dissent. Id. The high correlation between ethnicity and the disease has been linked to a reduced mortality rate in those areas
from malaria infection compared to other ethnicities that do not carry this mutated gene.
Id.
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verse employment effect based on this classification.175 First, the
plaintiffs alleged that African-American and female employees had been
singled out for the nonconsensual genetic testing.176 Therefore, the employer had selectively invaded the private medical information of a specific group of employees on the basis of race, and sex.177 Second, the
Ninth Circuit relied on past precedent that provides that Title VII prevents discrimination on the terms and conditions of employment.178 In
this case, the employer imposed a condition of employment on AfricanAmericans and females that it did not impose on all of its employees collectively.179 Finally, the Ninth Circuit remanded the case on the
grounds that the employer’s invasion into the private and sensitive medical information of its employees without their consent was sufficient to
constitute an adverse effect under Title VII.180
Based on language and interpretations, both the ADA and Title VII
adequately prevents employers from discriminating against employees
on a wide variety of characteristics. The Ninth Circuit has interpreted
genetic discrimination founded on a protected category as actionable
under Title VII. Additionally, the EEOC has interpreted the ADA as
covering genetic discrimination without a protected class category.181
175. Norman-Bloodsaw, 135 F.3d at 1265 (emphasis added).
176. Id. at 1271 (stating that the claim falls “neatly” within the framework of Title VII).
177. Id. at 1272.
178. Id. referencing Griggs v. Duke Power Co., 401 U.S. 424, 432-37 (1971); Hashimoto
v. Dalton, 118 F.3d 671, 676 (9th Cir. 1997); EEOC v. Hacienda Hotel, 881 F.2d 1504 (9th
Cir. 1989).
179. Id. at 1272.
180. Id.
181. Id. at 1269, 1272-73. The Ninth Circuit deemed that the unauthorized intrusion
into the private medical information regarding an employee was the, “most basic violation
possible.” Id. Additionally, a requirement of pre-employment health tests only administered to female employees or black employees would surely violate Title VII. Id. Plaintiff’s
brought an ADA violation against their employer and the Ninth Circuit dismissed the
plaintiff’s ADA claim holding that a because their employer had required the test after an
offer of employment had been made, but prior to the employer’s working as an employee,
the only restrictions the ADA places on an entrance exam are confidentiality requirements.
The Ninth Circuit reasoned that in this case the plaintiffs had not raised a claim relating to
their employer violating the confidentiality requirements under the ADA, and therefore did
not assert a claim upon which relief could be granted. Id. The plaintiff’s claim focused on
the scope of the examination, and because the ADA does not regulate the scope of a preemployment examination, the Ninth Circuit could not redress their claim. Id. See also,
Reginald C. Govan & Freddie Mac, Personnel, Investigative and Health Records, 763 PLI/
LIT 409, 582 (2007). The case was ultimately settled between the plaintiffs and the University of California for $2.2 million. Id. The settlement incorporated three, “subclasses of
employees—women who were tested for pregnancy, African-Americans who were tested for
sickle cell traits, and workers at the lab from January 1, 1981, and April 12, 1993, who
were tested for syphilis.” The affected class of persons included approximately 3,000 women who were tested for pregnancy and 900 African-American employees were tested for
sickle cell traits between 1972 and 1994 and between 1972 and 1995, respectively.” Id.; see
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Therefore, because no court has been afforded an opportunity to review
the EEOC’s interpretations, the enactment of GINA was premature. Additionally, it is inferable that a lack of genetic discrimination cases
brought by employees is evidence that genetic discrimination may not be
as great of a problem as Congress believed. The lack of litigation also
supports the conclusion that GINA was prematurely enacted.
B. ISSUES

WITH

TITLE II

OF

GINA AS ENACTED

The legislative history of GINA suggests that GINA was necessary to
ensure greater protection of an individual’s genetic information.182 Congress found that less than one percent (1%) of Americans have undergone genetic testing because they fear employers and health insurance
providers would use their genetic information for discriminatory purposes.183 However, as written, the provisions of Title II of GINA do not
prevent genetic discrimination in the workplace. Thus, Title II is problematic because it fails to fulfill the purpose of enacting the statute: to
provide a uniform standard of protection to employees’ nation-wide.
Additionally, GINA is confusing. GINA relies upon both broad provisions and definitions that raise potential compliance issues for employers and employees.184 Specifically, these broad provisions make it
unclear what is, and is not, covered under GINA. As a result, GINA will
merely be another federal employment law that was enacted with good
intentions that inevitably increases litigation, similar to the FMLA.185
also Griggs, 401 U.S. at 432-36 (noting that even if testing requirements appear facially
neutral, if they do not reasonably measure job performance and have a disparate impact by
preventing minorities from obtaining jobs, then the test violates Title VII).
182. Nancy Lee Jones, CRS REPORT FOR CONGRESS, GENETIC INFORMATION:
LEGAL ISSUES RELATING TO DISCRIMINATION AND PRIVACY, at 15, available at
http://www.ncseonline.org/nle/crsreports/science/st-55.pdf.
183. See The Library of Congress, supra note 11; see also H.R. 493 110th Cong. § 2
(2008).
184. See generally Energy and Commerce Hearing, supra note 151.
185. Derrick Kain, Discrimination-Legislation to Ban Genetic Discrimination in Workplace Clears House; Bush to Sign, [May] Daily Lab. Rep., at AA-1 (May 2, 2008), available
at http://pubs.bna.com/ip/bna/dlr.nsf/eh/a0b6k4p8r5. But see Energy and Commerce Hearing, supra note 151. While Fishman acknowledges that some people believe that their genetic information could be used against them regarding employment opportunities, that
fear is unfounded and misguided. Id. Fishman argues that this fear is, “fed by apocryphal
stories and, of course, on the rare but highly publicized cases involving Burlington Northern-Santa Fe Railroad, from nearly a decade ago.” Id. See also Linn F. Freedman, Privacy
of Genetic Info and Gina in An Electric Age, EMP. L. 360, Sept. 18, 2008, at 4; see also Tresa
Baldas, FMLA an Increasing Source of Litigation, Say Employment Lawyers, Jan. 1, 2007,
available at http://www.law.com/jsp/article.jsp?id=1168509734039.
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1. Non-preemption Contradicts Need for Uniform Protection
To adequately protect individuals, proponents of GINA argue that
there needed to be a uniform federal statute addressing genetic discrimination and enacted GINA in order to accomplish that goal.186 While proponents believe that GINA provides the necessary uniformity, GINA
does not preempt state law;187 therefore, it fails to provide a uniform
floor. GINA does nothing to remedy the state standards that impose inconsistent requirements because each state is allowed to retain its own
provisions on genetic testing so long as the laws are more comprehensive
than GINA. By not preempting state law, Congress’ intention of providing a uniform set of protections is undermined.188 If Congress wanted to
ensure uniform protection, it should have enacted legislation that imposes only one standard regarding genetic discrimination.189 Instead,
Congress has complicated compliance by allowing varying laws among
the several states.190
There is also a question of whether a real need for federal legislation, such as GINA, existed, or whether the individual states’ statutes
would have been sufficient. At the time GINA was signed into law,
thirty-four states had laws preventing employers from using genetic information to make employment decisions.191 Additionally, the states
that had genetic discrimination laws had yet to see litigation regarding
genetic discrimination in violation of these laws.192
186. See The Library of Congress, supra note 11.
187. See Id.; see also HR 493, 110th Cong. § 201(3)(b) (2008) (stating “nothing under
Title II of GINA shall be construed to limit the rights to an individual than the rights or
protections provided for under this title, including the protections of an individual under
the Americans with Disabilities Act of 1990 (42 U.S.C. § 12101 (1994)) including coverage
afforded to individuals under section 102 of such Act (42 U.S.C. § 12112 (1994)) or under
the Rehabilitation Act of 1973 (29 U.S.C. § 701 (1973))”).
188. Marian Waldmann, Timothy Verrall, & Christine Lyon, New Federal Law Regulates Collection and Use of Genetic Information By Employers and Group Health Plans,
BUREAU OF NAT’L AFFAIRS PRIVACY & SEC. LAW, May 19, 2008 at 764, available at http://
www.mofo.com/docs/pdf/BNA_GINA_May2008.pdf.
189. Id.
190. McGowan, supra note 18; see also Energy and Commerce Hearing, supra note 151
(stating that if Congress intends to enact a uniform statute it should include a “safe-harbor” provision that any employer in compliance with federal standards cannot be liable
under state or local laws banning such discrimination because there should be only one
standard, the federal standard).
191. National Conference of State Legislatures, State Genetics Employment Laws,
available at http://www.ncsl.org/programs/health/genetics/ndiscrim.htm.
192. Human Genome Project Information, Breaking News: GINA Becomes Law May
2008, http://www.ornl.gov/sci/techresources/Human_Genome/elsi/legislat.shtml (last visited Oct. 29, 2008).
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2. Broad Definitions Will Cause Confusion Regarding GINA’s
Application
Another issue is Congress’ use of broad definitions of family member
and genetic information.193 Congress expanded the definition of family
member to include information regarding the fourth-degree relative of an
individual.194 Under this provision, genetic information regarding an
employee’s mother, grandmother, great-grandmother, and great-greatgrandmother would be protected by GINA.195 While proponents of GINA
argue these broad definitions are needed to adequately protect highly
private and sensitive information, though Congress’ failure to narrow
the scope of these definitions could be problematic in application.196
Additionally, every type of genetic research is classified under a
broad heading of genetic information. However, because of the numerous types of genetic research and tests currently being preformed, experts have not reached a consensus on a precise definition of genetic
information.197 The lack of a formal definition is problematic because it
is not readily apparent what types of genetic information are precisely
referred to when the term is used.198
Genetic information not only includes the genetic information of individual employees and their family members, but also prevents discrimination based upon any manifestations of a genetic disorder in
employees’ family members.199 This provision was adopted to ensure
that an employer did not erroneously rely upon an individual’s genetic
predisposition of developing a disease based on the genetic tests of family
members in making its employment decisions regarding a current or prospective employee.200
While extending protection far into a family’s medical history is one
way to ensure genetic information remains confidential, it can also be
problematic. For example, extending protection under GINA to cover
family medical history presents a dilemma because medical histories do
193. Energy and Commerce Hearing, supra note 151. Fishman argues that “genetic information” under GINA should be defined with limitation regarding only a “genetic predisposition to develop a disease in the future.” Id. With the broad definition of genetic
information under the Act, the term could include the occurrence of a disease or disorder in
family members of the individual without any limitation.” Id. Fishman argues that based
on this usage, Congressional intent could be interpreted to include minor ailments such as
the cold, flu, and chicken pox under its provisions. Id.
194. H.R. 493, 110th Cong. § 201(3)(b) (2008).
195. Gordon, supra note 150.
196. Energy and Commerce Hearing, supra note 151.
197. Id.
198. See Electronic Privacy Information Center, Genetic Privacy, http://epic.org/privacy/
genetic (last visited Oct. 20, 2008).
199. Gordon, supra note 150.
200. Id.
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not provide the same information as a genetic test.201 This is problematic because the definitions are not clear or concise, causing confusion for
both employers and employees as to what is covered under the act, when
there is a lack of agreed interpretation issues arise.202
Also problematic is the broad definition of genetic information.203
Under GINA, genetic information covers information regarding an individual’s genetic tests, family member’s genetic tests, and the manifestation of a disease or disorder in an individual and the individual’s family
members.204 This definition is confusing, and will lead to numerous
questions by employers and employees as to what is covered under Title
II of GINA.205 Additionally, the definition of genetic information causes
difficulties because it may encompass family medical histories that are
used by an employer in reviewing an employee’s FMLA request.206 An
employer may require medical history as a requirement of granting an
employee’s FMLA request.207 If this information is used, however, it
could qualify as genetic information.208 Then, if an employer later took
an adverse disciplinary action against the employee, the employer could
subject itself to liability for genetic discrimination.209
As written, Title II is at odds with Congress’ intent for enacting
GINA because its provisions are vague. The need for a uniform statute
has not been established. Moreover, by enacting broad provisions, it remains unclear what is covered under GINA. Therefore, employees are
still not afforded clear assurance that genetic discrimination will be prevented by GINA. Analyzing these issues, it is apparent there are potential conflicts between GINA as written, and the potential outcomes of
enforcement.
C. POTENTIAL SOURCES

OF

LITIGATION

UNDER

TITLE II

OF

GINA

Historically, litigation increases when new legislation is enacted affording a private right of action.210 While it is conceivable that employers will not face an increase in litigation under GINA, it is likely that
201. Letter from the Genetic Information Nondiscrimination in Employment Coalition,
to Congress, (Jan. 23, 2007) available at http://www.nam.org/~/media/Files/s_nam/docs/
238200/238195.pdf.ashx [hereinafter Employment Coalition Letter].
202. Baldas, supra note 186.
203. Energy and Commerce Hearing, supra note 151, at 10.
204. H.R. 493, 110th Cong. § 201(4)(A) (2008).
205. Jo-el J. Meyer, Employee Benefits, Genetic and Disability Discrimination Laws
Play Role in Wellness Plans, Attorney Says, [Oct.] Daily Lab. Rep., (BNA) Oct. 7, 2008.
206. Id.
207. Id.
208. Id.
209. Id.
210. McGowan, supra note 18.
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litigation is inevitable.211 Not only is litigation likely to ensue, but there
will also be an increase in meritless claims under GINA. This is reflected in the EEOC’s 2006 finding that sixty-two percent (62%) of the
claims filed alleging workplace discrimination were deemed meritless.212
Additionally, there are provisions under GINA which will lead to
subsequent litigation once it takes effect. GINA affords a plaintiff a private right of action, entitling a plaintiff to compensatory and punitive
damages as well as equitable relief.213 With these kinds of damages and
remedies available to litigants, frivolous litigation is inevitable.214
While GINA sets forth new requirements and compliance demands
for employers, the damages scheme and enforcement provisions rely
upon Title VII.215 Under the provisions of GINA, damages cannot exceed $300,000, and the court will consider the size of the employer in
awarding an employee damages.216 In addition, a plaintiff may seek equitable relief in the form of future pay and back pay.217 It is the private
right of action provided through Title VII, and now GINA, that poses the
greatest likelihood of ensuing expensive and time-consuming trials and
resulting money damages under GINA.218
Unlike Title VII and the ADA, GINA differs in its enforcement provisions. There is no disparate impact clause provided under GINA, which
means a plaintiff cannot bring a claim alleging that a facially neutral
genetic policy is discriminatory.219 Additionally, a plaintiff who brings a
successful claim under GINA may obtain attorney’s fees.220 This is
counter to the American Rule, which usually requires a party to pay for
their own litigation expenses.221
211. Freedman, supra note 186 at 3. Reed Russell, legal counsel of the EEOC, predicts
that genetic discrimination claims are “reasonably rare.” Id. In response to whether GINA
is likely to cause an increase in litigation, Russell commented that “I don’t expect the statute to overwhelm us, though there may be some uptick in cases.” Id. Additionally, experts
in employment discrimination law do not believe that genetic discrimination cases will become as large of a basis for lawsuits as traditional protected classes such as race, gender,
and age. Id. No suits have been brought under state statute as well as federal statutes as
of the publication of this article. Id.
212. Employment Coalition Letter, supra note 202.
213. Freedman, supra note 186, at 4.
214. Agreed Order, supra note 158; see also Norman-Bloodsaw, 135 F.3d at 1273.
215. H.R. 493, 110th Cong. § 207(a) (2008).
216. McGowan, supra note 18.
217. Id.
218. Id.
219. McGowan, supra note 18.
220. 42 U.S.C. § 1988 (2006). A general attorney’s fees statute that provides for feeshifting in a cause of action for federal civil rights.
221. Title 4 Civil Resources Manual § 220 Attorney’s Fees, http://www.usdoj.gov/usao/
eousa/foia_reading_room/usam/title4/civ00220.htm [hereinafter Title 4 Manual]. The general rule in the United States is that each litigant is responsible for his own attorney’s fees.
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There are also serious penalties for relying on Title VII to enforce
the provisions of GINA because an employer who inadvertently discloses
genetic information may be held liable for both compensatory and punitive damages. Such damages awards by a court could be substantial.222
For instance, under the caps set forth in GINA, a large employer with
more than 500 employees could be held liable for $300,000 in compensatory damages and $300,000 in punitive damages.223 Furthermore, an
employee may bring suit under additional federal statutes, such as the
ADA or Title VII, in addition to GINA to obtain relief for genetic discrimination. GINA could end up being another act passed by Congress with
good intentions that leads to endless litigation for employers.224
Id. This common practice and knowledge has been dubbed the, “American Rule.” Id. See
also Alyeska Pipeline Serv. Co. v. Wilderness Soc’y, 421 U.S. 240 (1975). But see F.D. Rich
Co. v. Indus. Lumber Co., 417 U.S. 116, 129 (1974) (holding that proof of a party’s “bad
faith” such as willfully disobeying a court order or acting vexatiously, wantonly, or oppressively could warrant a court to award attorney’s fees to the opposing party).
222. Workplace Fairness, Damages, http://www.workplacefairness.org/damages#maincontent (last visited Nov. 15, 2008) [hereinafter Damages]. The purpose of compensatory damages is to make an employee who has been discriminated against by his
employer “whole.” Id. Compensatory damages are also referred to as “actual damages.”
Id. A court may award any of the following as part of compensatory damages: emotional
distress, pain and suffering, permanent disability, mental impairment, or medical bills.
Under Title VII, the amount of compensatory damages awarded to an employee is capped
based on the size of his employer. Id. If an employer has between fifteen and one hundred
(15-100) employees, compensatory damages are capped at $50,000. Between 101-200 employees, the cap is $100,000. Id. Between 201-500 employees, the cap is $200,000. Id. In
excess of 500 employees, the cap is $300,000. Id. Likewise, punitive damages are damages
awarded to an individual in cases where an employer has acted maliciously. Id. In employment cases, punitive damages are used to punish an employer and to set an example that a
specific type of conduct will not be tolerated by the courts. Id. In order to award punitive
damages, an employee must establish that an employer discriminated with reckless indifference. Id. However, the court does not consider the seriousness of the employer’s conduct
in making its determination whether to award punitive damages. Id. Instead, the court
focuses on the employer’s intent. Id. In other words, did the employer know that a particular action was unlawful discrimination and still choose to engage in that conduct anyway?
Id. An employer who adopts an anti-discrimination policy, effectively enforces that policy,
and thoroughly adopts that policy may rely upon good faith as a defense against punitive
damages awards and rely on the policy as evidence that the discriminatory practice did not
occur in the first place. Id. Punitive damages are only available against private employers.
Id. Punitive damages are also very rarely awarded to an employee. Id. This is in part
because if an employer expects that it will be liable for a large punitive damages award, it
will usually choose to settle the case out of court with an employee. Id. This is done to
avoid both large financial liability and prevent negative publicity. Id. When punitive damages are awarded by a court they can be substantial and are capped at the same amounts
as compensatory damages stated above. Id.
223. H.R. 493, 110th Cong. § 207(3) (2008); see also 42 U.S.C. § 1981(a) (1981).
224. Freedman, supra note 186 at 4. Michael J. Ossip compares “the good intentions
behind GINA to those underlying the factors that led to the passage of the Family Medical
Leave Act, which mandates unpaid leave for employees due to health reasons and other
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The FMLA is one example of how broad provisions lead to increased
litigation. The FMLA, enacted twelve years ago, caused an increase in
employees erroneously holding their employers liable for not granting
leave the employee was entitled to under the Act.225 Conversely, employers have claimed that their employees abused the FMLA by requesting time off for uses not covered under the statute.226 While most claims
under the FMLA are settled through administrative proceedings, there
has been an increase in employees relying on their private right to bring
suit in court.227
conditions.” Id. Regarding the FMLA, Ossip commented, “[w]hat was a deceptively simple
statute has turned into a decade plus of litigation, which doesn’t seem to be ending anytime
soon.” Id. However, Karen Rothenberg, dean of the University of Maryland School of Law
in Baltimore commented, “the law makes a ‘statement of social policy’ that genetic rights
are like traditional civil rights.” Id. Rothenberg disregards the argument that GINA will,
“open the floodgates to suit because of the difficulty in winning such cases and the toll it
may take on plaintiffs.” Id. See also Baldas, supra note 186.
225. Baldas, supra note 186. The Department of Labor reports that the number of
FMLA-related complaints has averaged around 3,000 per year for the last five years. Id.
Most of these complaints are settled out of court at the administrative level. Id.
226. Id. One major area of dispute between employees and employers under the FMLA
is whether stress-related illnesses constitute a “serious health condition” covered under the
act. Id. Employers have reported that employees are abusing the intended purpose of the
FMLA, by claiming that the flu or a headache entitles them to leave under the FMLA. Id.
Because tensions have risen in the past few years, the Department of Labor has launched a
public inquiry regarding whether the FMLA is serving its intended purpose of providing
twelve weeks of unpaid leave for a variety of health-related reasons. Id. The two most
litigated areas under the FMLA are the definitions of “serious health condition,” and when
an employee may request an unscheduled intermittent leave. Id. Intermittent leave permits an employee with a “chronic condition,” to take leaves of absences occasionally. Id.
The courts have not provided any serious guidance in this area, yielding conflicting interpretations that have only added to the confusion of employers, employees, and the Labor
Department. Id. Defense attorneys for employers maintain that this is a serious problem
that has become unmanageable, stating that employers have become “frustrated” with employee abuse of the FMLA. Id. Plaintiff’s’ attorneys argue that litigation under the FMLA
is a result of employers refusing to grant employees leave under the FMLA. Id. The Plaintiffs’ claim is directly supported by the 2002 victory for an employee who was retaliated
against by his employer for taking FMLA leave to care for his “aging parents.” Id. The jury
verdict in that case was the largest FMLA award of $11.65 million, and the case was settled on appeal for an undisclosed amount. Id. There is also a FMLA class action filed in
the Northern District of Illinois against AT&T alleging that the company visited the homes
of its employees to make sure that they were at home, monitored the employees’ “comings
and goings from their houses,” and notified certain employees that while under FMLA
leave they could only leave their homes to attend doctor’s appointments or to visit the drug
store. Id. Conversely, defense attorneys state that if employers are worried about litigation under FMLA being brought against them, if they are unclear about whether to grant
leave for an employee’s specific condition, they should err on the side of caution and “nine
out of ten times” grant the request. Id.; see also Butler v. Illinois Bell Telephone, No. 06 C
5400, 2008 U.S. Dist. LEXIS 11901 (N.D. Ill. Feb. 14, 2008).
227. See Baldas, supra note 186.
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The increased amount of litigation under the FMLA is a prediction
of the future legislative trend under GINA. Like the FMLA, GINA’s provisions are not clear to employers. Therefore, similar to the FMLA, employees can increasingly file complaints that genetic information is being
mishandled by their employer because they do not understand the provisions of GINA. On the other hand, the confusing terms under GINA
could also cause an employer to complain that employees are abusing the
provisions of GINA, because the company does not understand what information is protected. Moreover, like the FMLA, GINA affords employees a private right of action to bring suit in court if they are not satisfied
with the outcome of their administrative proceeding. Employees will increasingly rely on that right to bring litigation against employers.
Historically whenever Congress has relied upon broad provisions to
ensure wide coverage there have been enforcement problems. For instance, GINA’s broad definition of “genetic information” is similar to the
FMLA’s definition of “serious condition.”228 When the FMLA was first
enacted, there appeared to be a clear understanding between both employees and employers that a “serious condition” meant an illness that
was narrowly defined as potentially life threatening.229 In recent years,
there has been movement away from this strict interpretation to a more
liberal construction.230 The employers’ reliance on the broad use of “serious condition” led employers to grant leaves for conditions not originally
intended by Congress to be covered under the FMLA.231 Similarly, because GINA relies on broad definitions of “genetic information” and
“family members,” GINA will also cause confusion for employers and
misuse by employees.
Finally, the lack of litigation regarding genetic discrimination under
state statutes, the executive order, and federal law should not be interpreted as evidence that litigation will not occur under GINA.232 As tech228. See Id.
229. Id.
230. Id.
231. Id. When the FMLA was first passed, employers granted requests under FLMA
that were not “serious health condition(s).” Id. Employers have a duty to be compassionate
and understanding, but at the same time make sure that granting leave does not begin to
negatively impact the company. Id. These two goals are at odds with one another. Therefore, an employer must find a balance between compassion and doing those actions which
are in the best interest of the company. Id. This problem is furthered not only by frivolous
claims, but for those individuals who have conditions that should be protected under the
FMLA and do not fall into one specific category under the Act. Id. Further, some employers have chosen to ignore the law entirely even though the FMLA act has been on the books
for twelve years. Id.
232. Audio tape: Webinar Conference on GINA and the 2008 ADA Amendment, held by
Seyfarth Shaw LLP (Sept. 2008) (on file with author) [hereinafter Seyfarth Shaw Webinar].
Another important factor to consider in predicting whether litigation will occur under
GINA is to examine the number of genetic suits that have currently been brought under
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nology improves and the cost of genetic testing declines, health care
providers will rely more and more upon genetic testing as a healthcare
tool.233 As genetic testing becomes more predominant, the risk of genetic discrimination likewise grows exponentially. Therefore, as more
individuals undergo genetic testing, the pool of potential litigants increases as well.234
Now that GINA has taken effect, litigation is likely to ensue. Employees not only have a channel for relief expressly provided under
GINA, they may also rely on other federal statutes to bring suit. Past
genetic discrimination claims have been redressed by substantial
amounts, even though a plaintiff could not recover punitive damages.235
GINA, however, entitles a plaintiff to recover compensatory, as well as
punitive, and equitable relief. Therefore, even though damages are
capped, an award can still be substantial under GINA.236
D. STEPS EMPLOYERS SHOULD TAKE TO LIMIT LIABILITY

UNDER

GINA

To help prevent and limit liability, an employer must ensure that it is
in compliance with GINA’s Title II provisions.237 It is important to remember that GINA does not preempt more inclusive state statutes, and
there is no safe harbor provision under GINA; therefore, an employer
must also comply with state regulations.238
In order for an employer to ensure its compliance with GINA an employer must examine its current employment practices. In order to determine whether or not an employer’s current employment practices are
sufficient to comply with GINA, an employer should examine its nondiscrimination policies, current policies on the retention and disclosure of
employee medical information, benefit and wellness plans offered by the
employer, and electronic privacy practices. Most importantly, it is the
current state law. Id. Thirty-four states have statutes that prohibit employers from discriminating against employees on the basis of genetic information. Id. Additionally, Executive Order 13145 prohibits the government from discriminating against its employees on
the basis of genetic information. Id.
233. See Safe and Effective Testing, supra note 35.
234. Id.
235. Press Release, The United States Equal Employment Opportunity Commission,
EEOC and BNSF Settle Genetic Testing Case Under Americans With Disabilities Act (May
8, 2002), available at http://www.eeoc.gov/press/5-8-02.html (stating that the case was settled for $2.2 million).
236. H.R. 493, 110th Cong. § 207(a)(3) (2008).
237. Employment Coalition Letter, supra note 202 (noting a safe harbor provision would
make an employer who is currently in compliance with the provisions of a federal statute
immune from liability under state laws regarding that same form of discrimination).
238. Id. Discussions of the individual states’ laws on genetic discrimination are outside
of the scope and purposes of this comment.

\\server05\productn\S\SFT\26-4\SFT404.txt

538

unknown

Seq: 38

JOURNAL OF COMPUTER & INFORMATION LAW

20-APR-10

7:54

[Vol. XXVI

employer’s duty to ensure that its employees’ genetic information remains confidential.
1. Expand Current Nondiscrimination Practices to Include Genetic
Discrimination
GINA’s purpose is to prevent discrimination and should be complied
with in the same manner as other federal laws addressing discrimination. If an employer has an employment statement, it must amend such
statements to include language stating that the employer “will not discriminate against an individual in hiring, promotion, pay, fringe benefits, job training, classification, referral, and other aspects of
employment based on an individual’s genetic information.”239
In order to safeguard themselves from potential litigation, employers must also immediately stop any current practice of asking employees
for genetic information. Even if an employer believes it will not rely
upon genetic information in any discriminatory way, employers should
not ask employees for this information.240 In addition, an employer
should also no longer ask for an employee or applicant’s family medical
history.241
Requesting information regarding a family member’s medical condition to evaluate a leave request under the FMLA could subject an employer to liability.242 Thus, another safeguard employers must
implement is a policy, which avoids inadvertent disclosure of genetic information when requesting documentation to grant an FMLA request.
FMLA requests have the potential to disclose genetic information about
an employee’s family members’ genetic conditions.243 Even though this
practice is permissible under GINA, an employer should not engage in
this act in order to protect it from future litigation.244
239. DEP’T OF LABOR, EQUAL EMPLOYMENT OPPORTUNITY IS THE LAW, available at http://
www.dol.gov/ofccp/regs/compliance/posters/pdf/eeopost.pdf (noting equal employment opportunity statement should afford that an employer does not discriminate in hiring, promotion, discharge, pay, fringe benefits, job training, classification, referral, and other aspects
of employment on the basis of race, color, religion, sex (including pregnancy and sexual
orientation), or national origin).
240. Meyer, supra note 206.
241. Seyfarth Shaw Webinar, supra note 233.
242. McGowan, supra note 18. For example, an individual who reported on an FMLA
application that she needed time off to care for her mother who is suffering from breast
cancer has inadvertently disclosed the manifestation of a genetic condition to her employer.
Id. The employee could later use that incident to argue that the employer discriminated
against her if she was passed up for a promotion. Id.
243. Gordon, supra note 150.
244. Id.
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2. Minimize Risk of Inadvertent Collection
Litigation under GINA will most likely result from an employer’s inadvertent collection of genetic information.245 Employers’ inadvertent collection is often referred to as the water-cooler collection of employee
information.246 For example, suppose an employee disclosed to one of
his co-workers that there was a history of colon cancer in his family. If
his co-worker informed their employer, the employer would have inadvertently acquired genetic information about an employee. If the employee knew that his employer had this information, and later took an
adverse employment action against him, the employee could argue that
the action was a result of genetic discrimination.247
Additionally, while GINA prevents an employer from acquiring and
collecting genetic information from commercially and publicly available
sources such as newspapers, magazines, periodicals, and books that include family medical history, it does not specifically prevent the employer from using medical databases or court records.248 Therefore, an
employer should take extra precaution and assume there is a risk of inadvertent collection if genetic information is retained from medical
databases and court records. Court records and medical databases are
not expressly prohibited as sources of genetic information.249 Thus, to
minimize potential liability for inadvertent collection an employer
should implement a policy prohibiting the collection of any medical information from court records or medical databases.250
Moreover, GINA does not provide for the situation where an employer visits an employee at the hospital.251 During such a visit, there is
a possibility the employer could obtain information regarding an individual’s genetic information.252 If the employer were to take an adverse
action against the employee after such a visit, it is possible that the employee could file a claim alleging the action was based on the employer’s
discrimination of genetic information.253
Every person who undergoes a genetic test or has a known manifested disease in his family is a member of a protected class under
245. Interview with Steve Pearlman, Senior Associate, Seyfarth Shaw LLP, in Chicago,
Ill. (Oct. 9, 2008); Steve Pearlman, Senior Associate, Address on GINA at the Labor and
Employment Relations Association Lunch (Oct. 2, 2008) [hereinafter LERA].
246. LERA, supra note 246.
247. Id.
248. H.R. 493, 110th Cong. § 202(4) (2008).
249. H.R. 493, 110th Cong. § 206(b)(3) (2008).
250. H.R. 493, 110th Cong. § 206(b)(3)(B), (2008); see also Seyfarth Shaw Webinar,
supra note 233.
251. LERA, supra note 246; Seyfarth Shaw Webinar, supra note 233.
252. Id.
253. Id.
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GINA.254 It is argued that GINA has, in a sense, opened Pandora’s Box
for employers. Not a single human being has perfect genes.255 Therefore, because every individual has a predisposition to develop genetically
linked diseases in the future, every person has a basis for filing a claim
founded on genetic discrimination.256 Because the ramifications for inadvertent collection are substantial an employer must ensure that all
measures are taken to prevent inadvertent collection of genetic
information.257
3. Employment Benefits and Wellness Plans
GINA will play a major role in the future development of employee
benefits and wellness plans.258 As genetic testing becomes more common in future healthcare, it is realistic that an employer will offer genetic services as part of an employee benefit or wellness program.259
One of the new features employers are offering as part of their wellness
plans are health risk assessments (“HRAs”).260 An employer currently
offering HRAs as part of their wellness plans must ensure the medical
information collected does not violate the provisions of GINA.261 If an
HRA currently in place affects the ability of an employee to participate in
254. McGowan, supra note 18 (citing according to Rebecca Springer of Crowell & Moring, “the act is broadly written and creates an opportunity for an employee who has told his
employer of family history of alcoholism, for example, to claim genetic bias if he is subsequently fired”).
255. Ricardo Alonso-Zaldivar, Senate backs privacy for genetic data, L.A. TIMES, April
25, 2008 available at http://articles.latimes.com/2008/apr/25/nation/na-genes25.
256. Id.
257. See Agreed Order, supra note 158; see also May 8, 2002 Press Release, supra 236;
see also H.R 493, 110th Cong. §207(a)(3) (2008) (providing compensatory and punitive damages as well as other equitable relief).
258. Meyer, supra note 206. As employers continue to develop their wellness programs
that are centered on improving the health of their employees, they must take GINA into
consideration along with the Health Insurance Portability and Accountability Act, the
ADA, and Title VII. Id. A major trend among employers that provided wellness plans is to
offer employees two different plans, one for health and one for wellness. Id.
259. Gordon, supra note 150 (noting genetic counseling could be offered currently or in
the near future by employers as part of an employee benefit or wellness program); see also
National Society of Genetic Counselors, Genetic Counseling as a Profession, http://www.
nsgc.org/about/definition.cfm.
Genetic counseling is the process of helping people understand and adapt to the
medical, psychological and familial implications of genetic contributions to disease. This process integrates: interpretation of family and medical histories to
assess the chance of disease occurrence or recurrence, education about inheritance, testing, management, prevention, resources and research, and counseling to
promote informed choices and adaption to the risk or condition. Id.
See also Human Genome Project, Genetic Counseling, http://www.ornl.gov/sci/techresources/Human_Genome/medicine/genecounseling.shtml.
260. Meyer, supra note 206.
261. Id.
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a health plan, this would be a violation of GINA.262
Another facet of employer-provided wellness plans that must be reviewed are those plans that pay cash bonuses to employees for maintaining a certain level of health.263 A predisposition or diagnosis of a genetic
disease could prevent an employee from attaining a level of health that
would entitle him to a cash bonus. If an employee was denied a cash
bonus based on his genetic information, he could bring suit under
GINA.264 An employer need not sacrifice compensating employees all
together in an effort to take proactive steps to improve the health of its
own employees.265 Rather, there are other ways to encourage and award
employees who take an active role in improving their health such as bonuses for participation in fitness events or participation in stress-management classes.266
Under GINA, there is an exception for the acquisition of genetic information in accordance with employer-provided group-health and wellness plans.267 If genetic information is made available under this
exception, the information may not have any individual identifying characteristics, and must be provided to the employer in aggregate terms.268
GINA expressly states that information regarding an individual’s sex or
age cannot be disclosed to an employer.269 GINA, however, does not
mention disclosing information based on race or national origin. If an
employer lacks diversity among its employees, race or national origin
could be used to single out an employee if the genetic disease is associated with only one race or national origin. Thus, GINA makes it advisable for an employer to limit access to genetic information in making a
contribution or paying for genetic services.270
4. Duty to Maintain Confidentiality
An individual’s genetic makeup is extremely private information due to
its sensitive nature. Congress took this into consideration when drafting
GINA because it imposed a strict standard of confidentiality. GINA requires employers to treat an employee’s genetic information similarly to
any other medical information an employer keeps on file.271 Genetic in262.
263.
264.
ployees
265.
266.
267.
268.
269.
270.
271.

Id.
Id.
Id. (stating an example of current cash bonuses offered to employees include emwho reach certain blood pressure, cholesterol, and body mass targets).
Id.
Meyer, supra note 206.
H.R. 493, 110th Cong. § 202(b)(1)(A) (2008).
H.R. 493, 110th Cong. § 202(b)(1)(D) (2008).
H.R. 493, 110th Cong. § 201(4)(C) (2008).
Gordon, supra note 150.
Id.
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formation, therefore, should be afforded the same protection as medical
information under the ADA.272 This means that genetic information
must be labeled as confidential and preserved on separate forms in a
separate medical file. As an added precaution, accessibility must be limited on a strict need-to-know basis.273
Under the heightened confidentiality provisions of GINA, employers
must ensure that if they currently have, or obtain genetic information
regarding an employee, that the information is adequately protected.
Employers must review their current system regarding the storage of
medical files to see whether there are changes that must be made to accommodate the specific confidentiality provisions set forth under GINA.
One measure that should be incorporated is the training of individuals
who will have access to genetic information on how to determine whether
medical information constitutes genetic information under GINA.274 Additionally, an employer should require that genetic information be placed
into a separate file upon receipt to ensure that it is kept confidential.275
An employer should go as far as clearly labeling the information as genetic information, placing the information into a locked filing cabinet,
and even placing a note on the file that the information should not be
disclosed except through a court order.276
Moreover, GINA specifically affords very narrow circumstances in
which an employer can disclose an employee’s genetic information.
GINA, however, does not provide an exception for responding to a subpoena or civil discovery request.277 This is problematic because:
employment litigators, particularly on the defense side, commonly subpoena personnel files, including all medical information—for example,
to test a plaintiff’s allegations that the current employer’s alleged actions caused emotional distress. An employer that inadvertently produces genetic information in response to such a subpoena would violate
GINA because the act does not require a knowing disclosure to support
a claim.278

5. Compliance Could Evidence Good Faith Effort
Even if an employer takes every conceivable step possible to ensure
compliance with the provisions of GINA, litigation still may be inevitable
272. Id.
273. Id.; see also U.S. Navy, HIPPA Frequently Asked Questions, http://www.bethesda.
med.navy.mil/patient/hipaa/faqs.asp (last visited Nov. 27, 2008) (defining need-to-know basis as minimum necessary protections under the rule).
274. Gordon, supra note 150.
275. Id.
276. McGowan, supra note 18.
277. Id.
278. Id.; see also Employment Coalition Letter, supra note 202.
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as attorneys push the envelope as to what claims may be brought under
GINA. Litigation may be inevitable against an employer even if all measures provided for in this comment and beyond are implemented.
One incentive to employers to undertake immediate compliance
measures is that if an employer is sued it could rely on the compliance
steps previously taken to evidence of good faith.279 Because an employer
can be held liable for compensatory and punitive damages under
GINA,280 an ongoing commitment to compliance may show good faith,
thereby dissuading a court from awarding punitive damages.281
E. THE IMPORTANT PUBLIC POLICY CONCERNS

UNDER

GINA

GINA has been hailed as an important step in the movement from a
health care system focused on treating the sick, to a system focused on
prevention.282 Under GINA there is a sunset provision that will allow
Congress to revisit GINA in six years and make amendments.283 At that
time, there are three important policy concerns that must be considered
by Congress in order to ensure that GINA will prevent genetic discrimination. First, GINA must prevent employers from discriminating
against employees based on a likelihood of developing a disease in the
future. Second, GINA must afford adequate protection so that individuals will accept genetic testing as a part of the future of healthcare.
Third, the provisions of GINA should clearly reflect congressional intent
and yield uniform interpretations by the courts to limit potential
confusion.
1. Reduce Discrimination
Reducing the potential for discrimination is a major goal and value in
society today. There have been numerous cases litigated on behalf of individuals who have been historically discriminated against in order to
provide an equal opportunity for everyone regardless of individual characteristics.284 Discriminating factors have evolved over time from sex
and race to current issues of alien status and genetics.285 As technology
279. LERA, supra note 246.
280. H.R. 493, 110th Cong. § 207(a)(1) (2008).
281. See Alvarez v. IBP, Inc., 339 F.3d 894 (9th Cir. 2003) (rejecting employer’s good
faith argument where employer was on notice for three years to comply with the FMLA and
failed to do so). See also Damages, supra note 223.
282. See Zapata, supra note 134 at 5.
283. H.R. 493 110th Cong. § 208(b) (2008).
284. See GEORGE RUTHERGLEN, EMPLOYMENT DISCRIMINATION LAW: VISIONS OF EQUALITY
IN THEORY AND DOCTRINE 6-8 (Foundation Press 2d ed. 2007) (2001).
285. Id.; Howard F. Chang, Immigration and the Workplace: Immigration Restrictions
as Employment Discrimination, 78 CHI-KENT L. REV. 291 (2003); John C. Hendrickson, Selected Materials on Emerging Employment Discrimination Claims, 782 PLI./LIT. 403 (2008).
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progresses, the potential for discrimination based on internal genetic differences increases. One major concern about relying upon genetic information is that having the potential to develop a disease in the future
does not ensure the disease will manifest itself. Therefore, relying on
genetic information for discriminatory purposes places different treatment based on an individual’s characteristic that may not exist.
2. Encourage Genetic Testing
The ability to predict a predisposition of developing any genetic disease
is becoming more of a reality every day. The ability of a nation to adopt
and incorporate advancements in technology creates vast improvements
in the lives of its citizens, and can lead to an improvement in utility.286
Such an improvement in utility can be translated into a more productive
workforce, and therefore a more productive economy.287
There are numerous benefits provided by genetic testing. One of the
most beneficial is that genetic testing will shift the focus of the health
care industry in the United States away from a system focused on treatment, to a system focused on prevention. If an individual undergoes a
genetic test and finds out that he is predisposed to developing a particular disease, healthcare providers will be able to take steps to prevent the
disease from developing, instead of treating a disease after it has fully
developed.288 Moreover, a genetic test confirming that an individual is
predisposed to developing a disease in the future could encourage the
individual to make lifestyle changes. Immediate lifestyle changes could
prevent a disease from developing.289
Genetic testing will afford individuals the ability to learn about predispositions to genetic conditions and therefore take preventative measures to reduce the risk of a genetic disease manifesting later.
Additionally, as more genetic information becomes available, geneticists
will be able to develop individualized medicine to treat patients. This
has a dual benefit to employers. First, with individual tailoring of
medicine, an employee’s recovery time for serious diseases could be
greatly reduced.290 Thus, he potential loss in time for trial and error
treatments will reduce the length of time an employee is off work and
286. Dictionary.com, Utility, http://dictionary.reference.com/browse/utility (last visited
Nov. 30, 2008) (defining utility as that which is conducive to the happiness and well-being
of the greatest number).
287. Id.
288. NATIONAL HUMAN GENOME RESEARCH INSTITUTE, FINAL REPORT OF THE TASK FORCE
ON GENETIC TESTING (Sept. 1997), available at http://www.genome.gov/10001733.
289. Id.
290. See Monica G. Marcu, Personalized Medicine: Sweet or Bitter Pill?, THE SCI. ADVISORY BOARD, available at http://www.scienceboard.net/community/perspectives.107.html.
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will also reduce the amount an employer will spend on healthcare.291
Employer expenditures for healthcare will be reduced not only because
the disease will not be treated for as long, but also because employees
would not be undergoing unnecessary procedures.
3. Reduce the Potential for Excessive Litigation
In addition, there is a real potential threat of excessive litigation costs
for suits brought under GINA. Not only will excessive litigation tie up
the limited resources of the courts, but such litigation will require large
expenditures by employers to defend themselves.292 Moreover, the time
and expense associated with frivolous lawsuits could deter individuals
who have merit based claims from filing their own suits. Therefore,
there is a real need for measures to reduce the amount of litigation
brought under GINA and to ensure those claims brought in good faith
can be adequately investigated, pursued, and remedied.
These three policy goals must be kept in mind when GINA is revisited in the future, since the purpose of GINA was to reduce genetic discrimination. Therefore, Congress and the appointed taskforce must
ensure that GINA prevents genetic discrimination. Additionally, based
on the tremendous advantages of genetic testing, individuals must be
encouraged by GINA to undergo genetic tests. Finally, Congress and the
taskforce must prevent frivolous litigation under GINA. There must be a
balancing of these goals if GINA is to do all that it is intended to do.
IV. CONCLUSION
GINA was enacted by Congress with good intentions. Congress sought
to limit discrimination based on genetic information by employers and
health care providers; however, GINA, as currently enacted, is problematic. Current federal laws could have prevented genetic discrimination
making GINA duplicative. Additionally, because GINA was enacted
before a court interpreted genetic discrimination as not being protected
under current federal laws, it is also premature.
Until litigation arises under GINA, it remains unclear whether
GINA will live up to Congress’ expectations. However, as enacted, there
are issues under GINA that conflict with Congress’ intentions. The mandate for a uniform federal law is weakened by not preempting state laws.
The intentionally broad definitions relied upon in the legislation could
lead to a surge in litigation due to confusion by both employers and employees on how to interpret GINA. The reliance of GINA on a Title VII
enforcement scheme is also unduly harsh on employers who could be lia291. See Id.
292. See John Phillips, GINA: Goddess of Genes, http://employmentlawpost.com/the
word/2008/05/28/gina-goddess-of-genes/ (May 28, 2008, GMT 9:20).
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ble under its provisions for non-intentional disclosures of genetic information. These issues with the provisions of GINA will lead to litigation.
Historically, where a new private right of action is afforded to individuals, this right of action always leads to an increase in litigation.
Therefore, employers need to ensure that they are implementing practices now that will comply with the new regulations under GINA. An
employer must make clear that it does not discriminate against employees based on genetic information, minimize its ability to inadvertently
collect genetic information, examine current practices and remedy any
defects, ensure any genetic information it has is confidentially stored,
and realize the movement toward electronic storage of health information to ensure that their measures are current. Finally there are three
public policy goals that must be adequately promoted by GINA and subsequent legislation. Employees must be assured that their genetic predispositions will not be used adversely against them in employment
decisions. Employees also should feel free to undergo genetic testing not
only for personal benefits, but indirect benefits that could be realized by
the employer. Finally, with this expanded protection to employees, there
must be some type of control put forward to limit the number of frivolous
lawsuits brought against employers.

